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Abstracts 
Accessory sex glands (ASG) are glands along the male reproductive tract; 
their secretions form the bulk of seminal plasma during ejaculation. Previous 
studies in the golden hamster model have shown that the ASG are important in 
ensuring proper pre-implantation embryo development, such as oocyte activation, 
cell cycle regulation rate, cell death rate, embryo implantation and differentiation. 
Immediately before implantation, the embryos grow in the uterine fluid, the 
composition of which is regulated by secretory activities of the endometrium in 
response to the implanting embryo in addition to hormones. In this study, we 
hypothesize that mating involving males without ASG alters the composition of 
the uterine fluid in which the sperm and implanting embryo are bathed. We 
carried out a proteomic analysis of the post-coital and periimplantation uterine 
fluid soluble proteins in an attempt to identify regulatory proteins for embryo 
development. Golden hamster was used as our animal model. Males were divided 
into two experimental groups (VPX-ventral prostate bilaterally removed, TX-all 
accessory sex gland removed) and a control group (SH-sham operated). They 
were hand mated with females from which uterine fluid was flushed at 1,4, 60 
and 72h post coitum. Samples were separated by two dimensional 
electrophoresis followed by identification and validation of differentially 
expressed proteins by immunoblotting and RT-PCR. We conclude that omission 
• 
1 
of ASG secretions have initial and long term effects on uterine fluid and may be 
one of the mechanisms through which ASG secretions affect early embryo 
development in the hamster. Fourteen differentially expressed proteins were 
identified in 1 h post coital uterine fluid flushing. Tumor-necrosis-factor-alpha 
(TNF-a) induced protein 6 (TSG-6) was found in the 1 h post coital uterus. Nine 
differentially expressed proteins were identified in 60 and 72 h post coital uterine 
fluid flushing. Growth Differentiation Factor 8 (GDF-8) was localized in the 72 h 
post coital uterus. 
Our group had demonstrated previously that in addition to constituting 
post-coital uterine fluid, the VP secretion which was most important in embryo 
development specifically bind to sperms. In this study, VP proteins that 
specifically bind to sperm (SBVPP) was isolated by affinity chromatography, 
purified by gel filtration followed by analysis by two dimensional gel 
electrophoresis and matrix assisted laser desorption/ ionization time of flight mass 
spectrometer (MALDI-TOF). Eleven Proteins were identified and they included 
prostate specific antigen (PSA), Kallikrein 4 (KLK4), Kallikrein 10 (KLKIO) and 
prostatic acid phosphatase (PAP). We propose that these enzymes facilitate the 
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Chapter 1 General Introduction 
1 
1丄 The Male Accessory Sex Glands 
Semen consists of two major components: spermatozoa and seminal 
plasma. Spermatozoa are stored in the cauda epididymis until ejaculation. Seminal 
plasma is a highly complex fluid which contains secretions from the testis, 
epididymis and other accessory sex glands along the male reproductive tract 
(Mann and Lutwak-Mann, 1982; Aumuller & Seitz, 1990). Seminal fluid has 
been thought of as mainly serving as an agent to transport and nourish 
spermatozoa. In the female reproductive tract, the fluid that sperm are bathed in is 
further complicated by elements secreted by the vagina, uterus and oviduct. 
Interactions between the various components may have profound effects on the 
sperm, the mission of which is to ensure that the eggs are fertilized and that the 
sired embryos develop to be born. 
The mammalian male accessory sex glands consist of the prostate, 
coagulating glands, seminal vesicles, ampullary glands, Cowper's glands 
(bulbourethral glands), and glands of Littre; they vary in their topographical 
location, size, morphology, and functions (Knobil and Neill, 1994). 
The prostate glands are compound tubulo-alveolar glands present in all 
mammals that have been studied except the monotremes. It is the only accessory 
sex gland in carnivores such as the ferret, weasel, dog, and bear. Amongst the 
species, there are considerable variation in anatomy, biochemistry and physiology. 
The rodent prostate is composed of three pairs of lobes: cranial or anterior, also 
called coagulating glands, dorsolateral that nearly encircles the urethra 
dorsolaterally, and the ventral or posterior (Callow and Deanesly, 1935). In 
human, the gland is located behind the inferior part of the symphysis pubis and 
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rests directly above the urogenital diaphragm and in front of the rectal ampulla 
(Luke and Coffey, 1994). 
The seminal vesicles are paired, large and prominent tubuloalveolar glands 
located on the posterior side of the bladder and adjacent to the rectum. This gland 
can be found in human, rat and hamster but absent in the cat and dog (Aumuller 
and Riva, 1992). 
The Ampullary glands are glandular enlargements arising from the 
ampullae of the vas deferens. They may be only slightly glandular enlargements 
of the wall, or form discrete glands which nearly encircle the vas deferens as in 
the hamster. In mice and guinea pigs, they are vestigial. 
Besides these, there are mucus-secreting glands such as Cowper's glands 
and glands of Littre. They open into the urethra (Cossu et al, 1988). 
The golden hamster has the full set of accessory sex glands (Fig. 1-1) 
During the 60's, the only known function of male accessory sex gland 
(ASG) secretions is to contribute to the bulk of seminal plasma at ejaculation. 
From the 80,s onwards, studies show that the male accessory sex glands have 
many effects on gametes and the female reproductive tracts in difference kinds of 
mammals studied (Mann and Lukwak-Mann, 1982). They are also essential for 
the maintenance of fertility in several species of rodents. Removal of some or all 
of ASG has been shown to impair fertility in mice (Pang et al, 1979), rats (Queen 
et al, 1981) and guinea pigs (Lawlah, 1930). In hamster, total removal of male 
ASG or ablation of the ventral prostate (VP) alone does reduce fertility (Chow et 
al, 1986). Slower cleavage rate in preimplantation embryos is associated with 
greater implantation loss (O et al., 1988). In golden hamster, removal of ASG do 
not affect the percentage of ova fertilized and the cleavage rates during the first 
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two cycles of embryogenesis; however later, the cell number of embryos is 
reduced in females mated with males in which the ampullary gland or ventral 
prostate gland are removed (O et al, 1988). Although the functional significance 
of ASG in male mammals on the whole process of reproduction has not been 
clearly elucidated, a definitive role of these glands in rodents on fertility has been 
established (Chow and Pang, 1989). Recently its role in scavenging reactive 
oxygen species by ASG secretions to preserve sperm genomic integrity has been 
demonstrated (Chen et al, 2002). 
1.1.1. The Prostatic Complex 
Previous studies show that the human prostatic fluid is made up of a large 
amount of proteins which differ in enzyme activity and molecular size (Lilja and 
Abrahamsson, 1988). In rat, fructose is secreted by the dorsal prostate，whereas 
citric acid is produced by ventral prostate (Mann and Luwak-Mann, 1982). 
Polyamines such as putrescine, spermidine, and sermine are also secreted by the 
prostatic complex; and it has one of the highest polyamines concentrations of any 
tissue (Mann, 1974). Ions are also a major component in prostatic secretions. In 
golden hamster, the highest concentration of potassium, calcium and magnesium 
are found in ventral prostate; and the prostatic complex is the only zinc 
contributor to the seminal plasma among the accessory sex glands (Chow et al, 
1993). 
1.1.2. The Coagulating Gland 
The coagulating gland secretion is not essential for fertility in hamster. 
The coagulating gland is the principal protein contributor to seminal plasma; 
however the concentrations of sodium and chloride in coagulating gland were 
significantly lower than in the secretions of the other accessory sex glands (Chow 
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et al , 1992). The major function of coagulating gland is to secrete a clotting 
enzyme: transglutaminase; which coagulate proteins derived from seminal 
vesicles to form copulatory plugs in the vagina. This phenomenon happens in 
rats, mouse, guinea pigs, and several other mammalian species (Williams-
Ashman, 1984). 
1.1.3. The Seminal Vesicles 
The secretary products of seminal vesicles include ions, fructose, 
prostaglandins, endorphin; plasma proteins such as transferrin, lactoferrin, 
fibronectin, and specific proteins such as semenogelin, placental protein 5, protein 
kinase inhibitor, and carboanhydrase. The functions of these secretions include 
formation of seminal coagulum, modification of sperm functions such as motility, 
capacitation and immunosuppression (Aumuller and Riva, 1992). The seminal 
vesicle secretion make up about 70% of the seminal plasma. Removal of it 
changes the concentration of spermatozoa (Polakoski et al, 1976), and volume of 
ejaculate in human (Amelar and Hotchkiss, 1965); and in mouse lower the fertility 
(Pang et al, 1979). In bulls, the seminal vesicles secrete a prevalent protein called 
PDC-109, which binds to the midpiece of sperm during seminal emission. The 
protein changes the biophysical properties of sperm membrane and increases 
sperm motility (Sanchez-Luengo et al, 2004). In the house mouse, the removal of 
seminal vesicles reduces the number of fertilized eggs and changes the motility of 
uterine sperm (Peitz, 1988). The composition of seminal vesicle secretion is well 
studied. Nevertheless, the seminal vesicles of the golden hamster do not appear to 
be necessary for fertility (Chow et al, 1986). In rat, the vaginal plug is formed 
by enzymatic coagulation of secretions from the seminal vesicles and the 
coagulating glands. Studies of male rat with seminal vesicles partially removed 
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indicate that numbers of the spermatozoa reaching the uterus are lower. This is 
due to the size and position of the plug being lodged improperly into the cervical 
opening, and this phenomenon seems to be the most important conditions for 
promoting the rapid passage of spermatozoa into the uterus (Carballada and 
Esponda, 1992). Previous study shows that the motility of the house mouse 
uterine sperm is less progressive with more lateral displacement of the head about 
the trajectory and a less linear trajectory after removal of the seminal vesicles. 
The changes in sperm motility could contribute to the reduction in fertilization 
rate since sperm motility is necessary for their transport in the female reproductive 
tract and interaction with the oocytes (Peitz and Olds-Clarke, 1986). 
1.1.4. The Ampullary Gland 
In hamster, as well as laboratory mouse, citric acid is found almost 
exclusively in the ampullary gland secretion, but the function is still obscure. 
Also, the ampullary gland is the predominant contributor of sodium, and exhibit 
the highest specific activity for acid phosphatase in ampullary gland secretion 
among the accessory sex gland secretion. The ampullary gland secretion has 
relatively low protein content (Chow et al, 1992). In hamster, the removal of 
ampullary glands impairs fertility significantly because of polyspermic 
fertilization and premature death of embryos (Chow and O, 1989, Ying et al., 
1999). 
1.1.5. The Cowper's gland 
The Cowper's gland secretes glycerine-like clear secretion that often drips 
to the penis during sexual excitement. The function of this secretion is to flush and 
neutralize remaining urinary acid in the urethra as well as lubricating it 
(Coccannon et al, 1996) 
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1.1.6. The Littre's Gland 
The function of Littre's gland secretion is to lubricate the urethra during 
erection; it may also harbour infectious organisms in men suffering from certain 
social diseases (Cossu et al, 1988). 
1.2. The Uterus 
The uterus is the organ of gestation, receiving the fecundated ovum in its 
cavity, retaining and supporting it during development of the fetus, and becoming 
the principal agent in its expulsion at the time of parturition. It replaces the 
protection afforded oviparous animals by the eggshell and acts as the channel for 
supply of maternal nutrients to the embryo in the absence of yolk. 
1.2.1. The Structure of Uterus 
Three classic types of mammalian uteri have been described: the duplex 
type, the bicomuate type, and the simplex type. In human, the uterus is a "pear-
shaped" organ which consists of two parts: the body, with its upper broad 
extremity, the fundus; and cervix, or the neck, which is partly above the vagina 
and partly in the vagina. The uterus rests on the pelvic floor where it is 
maintained in place by ligaments and muscles. The uterine wall has three layers: 
an outer serosa, a middle muscular layer, the myometrium; and an inner mucous 
membrane, the endometrium. 
The arrangement of muscular tissue throughout the uterus is highly 
effective, especially for the evacuation of content. In the fundus, there is an outer 
covering of muscle which extends into the ligaments plus an internal muscular 
layer from which fibers enclose the orifices of the tubes and the internal aspect of 
cervical canal, acting as sphincters in those regions. In both layers, there is an 
elaborate network of muscle cells. Connective tissue sheaths containing a small 
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amount of elastic tissue surrounds individual muscle bundles. Blood vessels, 
lymphatics and nerves course in the sheaths. Between these layers, both of which 
are relatively narrow, lies the main portion of the musculature. The constituents 
are so arranged that they both promote evacuation and, by the orientation of 
individual cells toward one another, constrict adjacent blood vessels and assist 
haemostasis at delivery (Komorowski et al., 1970). 
1.2.2. The Endometrium 
The endometrium commences as a simple mucous membrane derived from 
the coelomic epithelium lining the Miillerian ducts (Hashimoto, 2003). During 
the peri-natal and pre-pubertal periods the glandular elements and their supporting 
stroma proliferate and gradually mature. At menarche, when pituitary and ovarian 
stimulations have become coordinated and effective，menstruation is initiated and 
recurring cycles commence. Histologically, the endometrium is made up of 
stroma and epithelium. The stroma can be subdivided into a basal layer (stratum 
basales) and a decidual layer (stratum functionalis). It contains epithelial， 
connective, vascular and lymphoid cells as well as connective tissue fibers and 
matrix (Gharpure, 1950). 
Stromal cells have large, pale nuclei with little cytoplasm and are typically 
spindle-shaped. They are involved in the production and remodeling of the 
extracellular matrix including synthesis and removal of collagen fibrils. The 
increased activity results in cells which are larger, with more protein-synthesizing 
machinery, and a nucleus with more euchromatin and more prominent nucleoli 
than at earlier stages. Stromal cells undergo their sequence of morphological 
changes apparently independent of epithelial cells. 
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Endometrial glands are made up of tall columnar cells arranged as a simple 
epithelium. They have large round or oval nuclei with their long axis oriented 
along that of the cell. Significant morphological changes are seen to correlate 
with the ovarian cycle. The endometrial glands extend through the full depth of 
the endometrium. The basal part of the glands lies in the basal layer, which is 
retained at menses, and is the source of the re-epithelialization which occurs after 
cessation of menstrual flow. The basal cells change little throughout the cycle. It 
is generally believed that the rest of the gland (in the functionalis) is lost every 
month during the non-pregnant reproductive life of an individual. An alternative 
view suggests that most of the endometrium is conserved and re-epithelialization 
occurs only in regions of localized damage (Bergeron, 2000). 
1.3. Identifications of Proteins by Two Dimensional Gel 
Electrophoresis and Matrix-assisted Laser Adsorption/ionization 
Time-of-flight (MALDI-TOF) Mass Spectrometer 
1.3.1. Principles of Two Dimensional Gel Electrophoresis 
Two dimensional gel electrophoresis is a widely used method for analysis 
of complex protein. The technique sorts proteins according to two independent 
properties: isoelectric points (pi) and molecular weight. 
For first dimensional separation, proteins are separated by their net 
charges. Proteins are amphoteric molecules that carry either positive, negative, or 
zero net charge, depending on the pH of their surroundings. The net charge of a 
protein is the sum of all the negative and positive charges of its amino acid side 
chains and amino- and carboxyl-termini. The isoelectric point is the specific pH 
at which the net charge of the protein is zero. Proteins are positively charged at 
pH values below their pi and negatively charged at pH values above their pL The 
presence of a pH gradient is critical to the lEF (isoelectric focusing) technique. 
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The principle o f lEF is that in a pH gradient and under the influence of an electric 
field, a protein will move to a position in the gradient where its net charge is zero. 
A protein with a positive net charge will migrate toward the cathode, becoming 
progressively less positively charged as it moves through the pH gradient until it 
reaches its pL On the other hand, a protein with negative net charge will migrate 
toward the anode, becoming less negatively charged until it also reaches zero net 
charge. 
lEF is generally performed at high voltages, typically in excess of lOOOV. 
The original method for lEF depends on carrier ampholyte-generated pH gradients 
in the polyacrylamide gel. Carrier ampholytes are small, soluble, amphoteric 
molecules with a high buffering capacity near their pL When a voltage is applied 
across a carrier ampholyte mixture, the carrier ampholytes with the highest pi 
move toward the anode and the carrier ampholytes with lowest pi move toward 
the cathode. 
For second dimensional separation, the proteins are separated on sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) according to 
their molecular weights. The technique is performed using polyacrylamide gel 
containing SDS. The intrinsic electrical charge of the sample proteins is not a 
factor in the separation due to the presence of SDS in the sample and the gel. SDS 
and proteins form complexes with neck-like structure composed of protein-
decorated micelles connected by short flexible polypeptide segments (Ibel, et al, 
1990). The result of the necklace structure is that large amounts of SDS are 
incorporated into the SDS-protein complex in a ratio of approximately 1.4g 
SDS/protein. SDS gives the charge of the proteins themselves and the formed 
anionic complexes roughly constant net negative charge per unit mass. Besides 
10 
SDS, a reducing agent such as dithothreitol (DTT) is also added to break any -S-
S-linkages present in the proteins. When proteins are treated with both SDS and 
DTT during equilibration steps, the degree of electrophoretic separation within 
polyacrylamide gel depends largely on the molecular weight of the protein. The 
most commonly used buffer system for second-dimension SDS-PAGE is the tris-
glycine system described by Laemmli (1970). This system confers the advantage 
of minimal protein aggregation and clean separation at relatively heavy protein 
loading. 
1.3.2. Principle of MALDI-TOF Mass Spectrometer 
Mass spectrometry is an analytical technique that measures the molecular 
weight of molecules based on the motion of a charged particle in an electric or 
magnetic field. The sample molecules are converted into ions in the gas phase 
and separated according to their mass: charge ratio (m/z). 
The ion source is the region of the mass spectrometer where gas phase ions 
are produced from sample molecules. The method of ion production is termed the 
ionization of peptide. Karas and Hillenkamp introduced matrix assisted laser 
desorption ionization (MALDI) in 1988 as a technique that could readily ionize 
biomolecules in a very sensitive manner. MALDI is a pulsed ionization technique 
which utilizes the energy from a laser to desorb and ionize the sample molecules 
in the presence of a light absorbing matrix. As this is a pulsed ionization 
technique, generating packets of ions with each laser pulse, a pulsed analyzer is 
typically required for separation and resolution of the ions. MALDI ions are 
created by mixing the sample with organic molecules which absorb light at the 
wavelength of the matrix. The sample becomes incorporated into the crystal of 
the matrix and is then irradiated with a laser. The laser stimulates the desorption 
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and ionization of the matrix and sample. Then the ions are accelerated to the MS 
analyzer. 
Consequently, MALDI is routinely coupled with a time-of-flight (TOF) 
analyzer. The TOF analyzers are one of the simplest type of MS analyzers. Ions 
produced in the ion source are accelerated by high voltage into the TOF analyzer, 
acquiring an initial velocity that is dependent on their mass. The time of flight of 
an ion is typically measured as the time the ion takes to traverse the flight tube to 
the detector from the source. The analyzer affords a high sensitivity and 
theoretically an unlimited mass range. Mass measurement is recorded by the time 
of flight of an ion in the flight tube. The time of flight of an ion is proportional to 
the square root of its mass/charge ratio given a constant accelerating voltage. 
Finally, the MALDI-TOF data is submitted to a database for peptide mass 
fingerprinting. The technique originally described in 1993 comprises protein 
digestion, MALDI-TOF analysis and sequence database search algorithms 
(Henzel et al, 1993; James et al, 1993; Mann et al, 1974; Pappin, 1997 and 
Yates et al, 1993) Every protein in the protein database is theoretically digested 
with the cleavage reagent used in the digestion reaction, generating many 
hundreds of thousands of theoretical peptides. The experimental peptide masses 
can be derived from the MS spectrum, the peptide mass fingerprint is then 
compared to the theoretical peptide masses and a score is calculated and assigned. 
The score reflects the match between the theoretically and experimentally 
determined masses. The protein identified as the most probable is the one that 
gives the best match between the experimental and the theoretical peptides. 
Several programs are available to perform this kind of search. 
1.4. Hypothesis and Aim of this Study 
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1.4.1. Hypothesis 
In this study we hypothesize that omission of secretions from ventral 
prostate or all ASG alters the profile of soluble proteins in uterine fluid and may 
account for the reduced fertility. We know that ventral prostate is important for 
early embryonic development. Previous studies show that mating that involves 
males with removal of ventral prostate or all ASG results in reduce fertility by 
adversely affecting embryo development. The effect could be on the sperm and 
the embryo which share one common property in that they are bathed in uterine 
fluid. 
1.4.2. Aim 
The aim of this study is to: 
1. Investigate the effect of omission of secretions of ventral prostate gland or 
all ASG on the profile of soluble proteins in uterine fluid at the time of 
mating and around the time of implantation 
2. Identify proteins that are differentially expressed at these time points 
3. Identify ventral prostate secretory proteins that are specifically bound to 
sperm surface 
Proteomic analysis by two dimensional electrophoresis; identification of 
proteins of interest by MALDI-TOF and confirmation of proteins identified by 
Western blot and RT-PCR were carried out. 
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Legends and Figures 
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Fig. M 
An illustration of accessory sex glands (ASGs) in hamster. The ASGs sit along the 
male reproductive tract, and their secretions form the bulk of seminal plasma. In the 
natural reproductive process, it provides a medium to facilitate active and passive 
transport of sperm. In addition it affords protection and nourishment to sperm. ASG 
are well-developed in the hamster and the components are pointed out on fig. 1-1. 
ASGs includes seminal vesicle (SV), coagulating gland (CG), ampullary glands 
(AG), ventral prostate (VP) and dorsal prostate (DP) (not shown on picture). 
(From Professor P.H. Chow) 
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Chapter 2 The Effect of Omission of Male Accessory Sex 
Gland Secretions on Post Coital Uterine Fluid 
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2.1. Introduction 
2.1.1. Uterine Fluid at the Time of Mating 
Both seminal plasma and sperm in semen are antigenic to the uterus and 
induce innate immune response after mating. One of the functions of seminal 
plasma is to inhibit or modulate immunosuppressive activity. Because of this 
interaction, from the moment the sperms enter the uterus enormous changes take 
place in the uterine lumen. 
Engelhardt et al., (1997) has reported that mating induces an influx of 
inflammatory leukocytes into the endometrial stroma and uterine lumen in pig. 
This response is partially under endocrine control induced by components in 
seminal plasma. The distribution of immune cells such as helper T-cells (CD4+) 
and cytotoxic T-cells (CD8+) in endometrium of the mare were studied previously. 
Six hours after insemination, significant increase in helper T-cells was found. 
However, the number of cytotoxic T-cells remains unchanged (Tunon, et al., 
2000). Previous study by Ying Yijun (1998) demonstrated that in female 
hamsters, lymphocytes are mainly distributed in the subepithelial part of the 
stroma up to 6 h after mating. The numbers of lymphocytes increase significantly 
relative to that compared with on day 2 of the estrous cycle. This phenomenon 
explains that the uterus presents a picture of sudden and acute inflammatory 
response after mating. 
Para-aortic lymph node (PALN) lymphocytes is principally T and B 
lymphocytes, with smaller populations of CD3 (+) B220 (lo), NKl.l (+) CD3 (-) 
(NK) and NKl.l (+) CDS (+) (NKT) cells. Recent study by Johansson's group 
(2004) verified that the activation and expansion of PALN lymphocytes occur 
after mating in female mice, and was triggered by constituents of seminal plasma 
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derived from the seminal vesicle glands. Synthesis of cytokines including 
interleukin-2 (IL-2), interleukin-4 (IL-4) and interferon-gamma (IFN-y) was 
elevated in CDS (+) PALN cells after exposure to semen. In contrast, males from 
which seminal vesicle glands were surgically removed failed to stimulate PALN 
cell proliferation or cytokine synthesis (Johansson et al” 2004). 
Conversely, insemination also induces release of anti-inflammatory 
molecules such as interleukin-10 (IL-10). IL-10 is secreted by leukocytes and 
somatic cells on day 1 of pregnancy in mouse in response to activation by factors 
in seminal plasma (White, et al., 2004). IL-10 terminates inflammatory responses 
and limits inflammation-induced tissue pathology by inhibiting synthesis of tumor 
necrosis factor a , interleukin-1 (IL-1), and a large array of other pro-inflammatory 
cytokines and chemokines by monocytes/macrophages (Moore, et al., 2001). 
Consequently, the anti-inflammatory properties help the sperm to survive in the 
female reproductive tract. 
Seminal plasma has been shown to suppress T- and B-cell proliferation in 
response to mitogen or antigen challenge; impair neutrophil and macrophage's 
ability to recognize target antigens by means of surface cytophilic antibodies; 
impair the ability of killer cells and cytotoxic T cells to recogonize and destroy 
tumor and virally infected target cells and inhibition of phagocytosis by 
macrophages and polymorphonuclear leukocytes (Christian 1989). The activity of 
Granulocyte/macrophage colony-stimulating factor (GM-CSF) also induced by 
the presence of seminal plasma. The GM-CSF could be compensated for or 
augmented by an array of other chemokines which synthesized by epithelial cells 
and activated endometrial macrohages. Those chemokines include granulocyte-
colony stimulating factor (G-CSF), colony stimulating factor-1 (CSF-1), IL-1, 
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interleukin-6 (IL-6) and TNF-a are also up-regulated after mating (Kaushansky et 
al., 1988; Robertson et al., 1992; and De et al, 1992). 
Dramatic fall in the lymphocyte subpopulations was present in the uterine 
epithelium and subepithelial stroma in glits which has mated with vasectomized 
boar. Also, an increase in MHC class 11+ macrophages and dendritic-like cells 
beneath the endometrial glandular epithelia. (Bischof et al., 1994). Studies in 
mice with similar changes in the presence and distribution of endometrial 
leukocytes suggest that the effects observed after mating are due to seminal 
plasma components rather than the mechanical stimulation associated with the act 
of mating (McMaster et al., 1992) 
Besides seminal plasma, sperm also interact with endometrium. The 
insemination of mares with equine sperm induces an influx into uterine lumen of 
polymorphonuclear neutrophils (PMNs) which phagocytose the sperm. This is 
important for clearing excess sperm in the female reproductive tract. The sperm 
are probably oponsized as equine sperm has been demonstrated to activate 
complement in uterine secretion in in vitro (Troedsson, et al., 2001). 
2.1.2. Ventral Prostate Secretory Proteins 
The sperm is a highly specialized cell with little cytoplasm and highly 
condensed nucleus, the sperm has little transcriptional and translational activities. 
The sperm's properties and functions are mainly gained from capacitation and 
acrosome reaction during the journey to meet the oocyte. During this long 
journey, the sperm is exposed to the secretions from testis, epidermis, accessory 
sex glands, vagina, uterus, and oviduct. Since seminal plasma forms the bulk of 
semen, sperm are most likely to be in contact in particular, secretions from ASG. 
Ablation of some or all male ASG results in significant reduction in fertility. For 
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example, the removal of dorsal prostate and ventral prostate glands in mice (Pang 
et al., 1979), and total removal of the glands or ablation of the ventral prostate or 
of the ampullary glands alone in golden hamster (Chow et al., 1986). In the 
golden hamster model, the ventral prostate gland has been shown to be most 
important for maintaining fertility; the present study has concentrated on it. 
Seminal plasma from normal fertile men has over 200 proteins that range 
in molecular weight from 10 to 100 kDa. Most of them originate from the 
prostate complex (Aumuller and Seitz, 1990). Those proteins include prostate-
spedfic antigen (PSA), which is 33kDa glycoprotein purified from normal 
prostatic tissue (Wang et al., 1979). Human PSA is also known as kallikrein 3; it 
shows proteolytic enzyme activities and is mainly responsible for proteolytic 
degradation of the seminal gel formed immediately after ejaculation 
(Abrahamsson and Lilja, 1990). Prostatic acid phosphatase (PAP) is a 45-47kDa 
glycoprotein (Abrahamsson and Lilja, 1990). Prostate-specific protein 94 (PSP-
94) is also known as p-microseminoprotein (P-MSP). PSP-94 is a 10.7kDa 
nonglycosylated protein purified from human seminal plasma. It is a major 
secretory protein highly expressed and synthesized by the lateral lobe of prostate 
glands in both rat and mouse, and moderately expressed in the dorsal lobe of the 
rat prostate glands (Kwong et al., 2003) In addition, Zn-a glycoprotein, seminal 
neuroendocrine peptides and amine (somatostatin and serotonin) and thyrotropin-
relasing hormone-like peptides (TRH) or fertilization promoting peptide (FPP) 
have been described and have been identified as coming from the prostate in 
rabbit, mouse, and human (Cockle et al., 1994). 
SDS-PAGE shows that the human prostatic fluid is made up of a mixture 
of a large number of proteins differing in their enzyme activities and molecular 
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weights (Lilja and Abrahamsson, 1988). Estramustine binding protein (EBP) is an 
androgen dependent secretory protein. It is a 46 kDa glycoprotein which 
specifically binds to estramustine and was first discovered in rat ventral prostate 
(Shiina et al, 1997). Prostatein is a major protein produced and secreted into the 
seminal fluid by the rat ventral prostate and has effect on the phagocytic cell 
functions in vitro. Recent study shows that the prostatein can inhibit macrophage 
function, showing an important antioxidant effect (Maccioni et al., 2003). Some 
androgen-regulated proteins are synthesized and secreted by rat ventral prostate. 
Those proteins included prostatic binding protein (PBP), the proline-rich 
polypeptides (PRP) and the 20 or 22 kDa protein, which respectively constitute 
approximately 50, 5, and 10% of the secreted protein (Heyns, 1990). 
Prostasomes are lipid vesicles specifically secreted by the prostate into 
human semen. It is involved in several physiological functions such as the 
improvement of sperm motility, immunomodulation, such as reducing the overall 
oxygen species produced by seminal polymorphonuclear neutrophils (PMN) and 
inhibits NADPH oxidase activity of blood or seminal PMN (Saez et al., 2000). 
Regulation of the production of reactive oxygen species in the reproductive tract is 
extremely necessary to prevent their deleterious effects on the sperm motility and 
the fertilization process. 
2.1.3. Proteins Specifically Bind to Sperm Membrane 
In the golden hamster, the ventral prostate and ampullary gland are 
essential for maintaining fertility (Chow et al., 1986). Previous studies show that 
the sperm plasma membrane proteins, especially glycoproteins, are modified after 
exposure to ampullary gland or ventral prostate secretions in vivo and in vitro 
(Cheng et al., 1994). However, this modification does not seem to have serious 
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effects on sperm functions such as sperm motility, capacity, acrosome reaction 
and sperm-egg recognition as the rate of fertilization in vitro and in vivo are not 
affected by deletion of some or all of the ASG. 
A major cause of immunological infertility is antisperm antibodies in 
seminal fluid (Claudia et al, 2001). They may bind to sperm surface (Anderson 
and Hill, 1988). A recent study using 2-D electrophoresis, mass spectrometry, 
peptide matching and western blotting to find out 18 sperm membrane antigens 
which are bound to antisperm antibodies from infertile man seminal plasma. Six 
of the recognized proteins were analyzed by means of: HSP70 and HSP70-2, 
disulfide-isomerase-ER60, caspase-3 and two subunits of the proteasome 
(Bohring and Kmuse, 2003). The proteasome is a multienzymatic protease 
complex is present in human sperm. Recent study shows an extracellular 
localization of proteasome on the plasma membrane of the sperm head (Morales et 
a/., 2004). Another study prove that the human sperm proteasome involved in the 
exocytosis of the acrosome, perhaps in events upstream of the plateau phase of the 
Ca (2+) influx (Morales et al., 2003) 
Research also shows that the only characteristic required for phagocytosis 
of sperm is an intact plasmalemma which suggests that sperm have a surface 
molecule critical to binding and uptake by the macrophage (Olive and Schlaff, 
1988). 
Aim of Study 
The aim of this chapter is to: 
1. demonstrate that some soluble proteins in the uterine fluid are also found 
in serum 
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2. prove that ablation of male ASG alters the profile of post coital uterine 
fluid proteins 
3. prove that some VP secretory proteins specifically bind to sperm 
membrane 
4. identify protein of interest in (2) and � by proteomic techniques such as 
two dimensional electrophoresis and MALDI-TOFF 
5. confirm identified proteins with western blotting and polymerase chain 
reaction technique 
2.2. Materials and Methods 
All solutions and buffers were listed on appendix A. All reagents were of 
the highest grades and were purchased from Sigma, St. Louis, MO, U.S.A. unless 
otherwise specified. 
2.2.1. Animal Model 
The golden hamsters {Mesocricetus auratus) used in this study were 
supplied by the Laboratory Animal Services Center of the Faculty of Medicine, 
The Chinese University of Hong Kong. Protocols for handling of animals were 
approved by the Animal Research Ethics Committee of the same University. Both 
male and female hamsters were ear-marked for identification. 
2.2.1.1. Female golden hamsters 
Female hamsters aged 8 to 12 weeks were caged in groups of 5 with food 
and water supplied ad libitum. They were kept in a temperature- and humidity-
controlled room under a 10-hours-dark and 14-hours-light cycle with lights on at 
eleven o'clock in the morning, and light off at one o'clock at night. The oestrous 
cycle was precisely regulated by photoperiod in hamster (Austin, 1956; Orsini, 
1961). Under precise light-dark cycle adopted in the present study, females 
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ovulated once every 4 days, at about seven hours after onset of darkness on day 2 
of the oestrous cycle. The vaginal discharge on day 2 is easy to distinguish, 
because it is creamy and smelly. The discharge can be squeezed out by gently 
applying pressure on both sides of the genital orifice. Only females demonstrating 
two consecutive regular oestrous cycles were used for mating with a single male 
from any of the three experimental groups on day 2 of the oestrous cycle. 
2.2.1.2. Male golden hamsters 
Male hamsters were divided into three groups: sham operated group (SH), 
ventral prostate glands bilaterally removed group (VPX) and all accessory sex 
glands removed group (TX). Before operation, eight weeks old male hamsters 
were anaesthetized with ketamine/xylazine mixture at a dose of 1.0 mg/0.1 mg per 
10 g body weight in a volume of 0.1 ml 0.85 % saline. SH group hamsters were 
controls in which the abdomen was opened to expose the ASG. For VPX and TX 
groups, the accessory sex glands were exposed and under the dissecting 
microscope, bilateral removal of the ventral prostate glands only or all ASG were 
removed as described by Chow (1986). The incisions were closed with sutures 
and autoclips. After the surgery, the male hamsters were maintained under the 
same conditions as for females. 
The operated male hamsters were not mated with the females until three 
weeks after the surgery. The samples from the first two mating were not used for 
data collection. Also, males were not mated more than once every three days. 
The operated males were retired about 8 to 9 months at which time they were 
euthanized with excess chloroform inhalation and inspected post-mortem for 
success of surgery. Their thoracic and abdominal cavities were opened and 
condition of the viscera, accessory sex glands and reproductive tracts were 
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examined. Only data collected from successfully operated males with patent 
ductal systems were used for analysis of results. 
2.2.2. Collection of Biological Samples 
2.2.2.1. Female Hamster Serum 
The female hamsters were anaesthetized with ketamine/xylazine 
mixture at a dose of 1.0 mg/0.1 mg per 10 g body weight in a volume of 0.1 ml 
0.85 % saline. Then their thoracic and abdominal cavities were opened. The 
blood was drained from their right ventricle. The blood was then centrifuged at 
2000g for 5 min. Then the serum was collected and was kept at -70�C until use. 
2.2.2.2. Uterine Fluid 
Samples were collected at 1, 4 h after mating from three experimental 
groups (SH, VPX, and TX). Also, samples were also collected from day 2 non-
mated female. The females were sacrificed by excess chloroform inhalation and 
their thoracic and abdominal cavities were opened. Both uterine horns were 
removed and placed on filter paper and blood and connective tissues were cleared. 
Each uterine horn was flushed with 500|li1 0.85% saline (Appendix A) with 
protease inhibitor. One protease inhibitor cocktail tablet (Roche, Germany) was 
dissolved in 7ml saline according to the manufacturer is instructing. The enzyme 
concentration of each inhibitor in the tablet was listed on Appendix F-6. The 
sample was centrifuged at 4286g for 8 min to collect the supernatant. One ml 
lysis buffer (Appendix A) was added to each sample and the mixture was kept on 
ice for at least three hours. After incubation, the sample was concentrated and 
desalted by Amicon Ultra-4 Concentrator with lOK cutoff (Millipore, Billerica, 
MA). Finally, protein concentration of the lysate was determined and the sample 
was stored at -70°C until use. 
26 
2.2.2.3. Uterine Tissues 
Uterine tissues samples were collected at 1, and 4h after mating from three 
experimental groups (SH, VPX, and TX). The uteri were removed as described in 
the previous section. Then, the uteri were flushed with 0.85% saline and were 
stored at -70°C until RNA extraction. Some of the uteri were stained with 
Hematoxlin and eosin. 
2.2.2.4. Ejaculated Sperm in Uterus 
Uteri were collected at 1 and 4 h post coitum for the three experiment 
groups. The uteri were removed as described in section 2.2.2.2.. Both ends of the 
uterine horns were tied up so as not to disturb the uterus with uterine sperm. The 
samples were then kept for scanning electronic microscopy (SEM). 
2.2.2.5. ASG Secretions 
Six to eight months old male hamsters were sacrificed by excess 
chloroform inhalation and their thoracic and abdominal cavities were opened. 
Ventral prostate, dorsal prostate, ampullary gland, coagulating gland, and seminal 
vesicle were removed under a stereomicroscope. Each pair of glands was placed 
on aluminum foil separately on ice. The secretion of seminal vesicle was easy to 
collect, it flowed out without squeezing. Protease inhibitor solution prepared as 
described in section 2.2.2.2. was added to the sample immediately in 1:6 ratio. 
For collection of secretion from the other glands, several cuts were first made by a 
pair of fine scissors, followed by applying protease inhibitor solution directly onto 
the glandular tissues to flush out the secretions. The volume of the secretion was 
measured by micropipette; then the protease inhibitor solution was added in a ratio 
of 1:3. The secretions were centrifuged at 4286g for 8 min to remove cell debris, 
the supernatant was collected. Lysis buffer was added to sample in 1:1 ratio, and 
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kept on ice for at least three hours. After incubation, the sample was concentrated 
and desalted by Amicon Ultra-4 concentrator with 10 K cutoff (Millipore, 
Billerica, MA). Finally, protein concentration of the lysate was measured and the 
sample was stored at -70''C until use. 
2.2.2.6. ASG Tissues 
The ASG tissues collected from the previous section were kept for RNA 
extraction. The contents were squeezed out and washed with 0.85 % saline. 
2.2.2.7. Epididymal Sperm 
Normal male hamsters 3-5 months old were sacrificed by chloroform 
inhalation. After opening up the abdominal cavity, the cauda epididymides 
together with the vasa deferentia were removed. Fat, blood and connective tissues 
were cleared off and a cut was made on the epididymal tubules. Using a 25G 
hypodermic needle with the sharp tip filed off, the sperm were flushed out by 
retrograde perfusion through the vas deferens with 5 mM HEPES/0.264 mM 
sucrose buffer pH 7.4 containing 2 mM phenylmethylsulfonyl fluoride (PMSF) 
and 10 mM iodoacetamide. The sperm were washed three times (600g, 5 min each 
at 4 � C ) in 10 volumes PBS containing 2mM PMSF and lOmM iodoacetamide) in 
round-bottomed centrifuge tubes. The supernatant was discarded and the sperm 
pellet was suspended in the buffer and the number of sperm was counted by a 
haemocytometer. Sperm concentration was adjusted to about 2 x 10^ sperm/ml. 
2.2.3. Isolation and Purification of Sperm binding Ventral Prostate 
Proteins (SBVPP) 
SBVPP were isolated by affinity chromatography followed by gel 
filtration. 
2.2.3.1. Plasma Membrane Protein from Epididymal Sperm 
28 
One ml of the epididymal sperm suspension was centrifuged at 600g for 5 
min at 4 � C . The sperm pellet was resuspended in suspension buffer (Appendix A) 
and left on ice for 20 min. After that the sperm suspension was centrifuged at 
lOOOOrpm for 15 min. The supernatant containing the sperm membrane protein 
was removed and diluted 10 times with double distilled water and the pH adjusted 
to 7.8 with 1 N NaOH. The suspension was loaded onto a DEAE-Biogel A (Bio-
Rad, Hercules, CA) column (2X18cm) that had been pre-equilibrated with 0.02 M 
Tris-HCl buffer, pH 7.8. After loading, the column was washed with several bed 
volumes of equilibrating buffer 1. Sperm membrane proteins were then eluted 
with 0.02M phosphate buffer pH 5.8 containing 1 M NaCl. The elute was 
concentrated by using Centricon-3 (Millipore, Billerica, MA), dialysis against 
water using dialysis tube with molecular weight cut off of 6-8 kDa (Spectrum 
Medical Industries) followed. Finally the proteins were collected, lyophilized, 
and stored at -20 
2.2.3.2. Affinity Chromatography 
Ventral prostate proteins that bind to epididymal sperm membrane was 
isolated by affinity chromatography. Four gram CNBr-activated Sepharose 4B 
dry powder (Amersham Bioscience, Sweden) was suspended in 1 mM HCl and 
washed several times for 15 min each with ImM HCL Fifty milligram lyophilized 
sperm membrane protein was dissolved in 20 ml 0.1 M NaHCOs, and centrifuged 
at 10,000g, for 10 min. The suspension was mixed with the gel in a vessel with a 
stopper. The mixture was then rotated end-over-end for 1.5 h at room temperature. 
The excess sperm membrane proteins were washed away with at least 70 ml 
coupling buffer and centrifuged at 600g for 10 min. Any remaining active groups 
were blocked by transferring the gel to 0.1 M glycine buffer (pH 8.0), and let 
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stand for 2.5 h. The sperm membrane-CNBr-Sepharose 4B gel was then packed 
into a column with the dimension of 1.5 cm X 10 cm. Three wash cycles were 
applied to remove non-covalently adsorbed proteins. Each cycle consisted of a 
wash at pH 4.0 with 0.1 M acetate buffer containing IM NaCl followed by a wash 
with 0.1 M Tris-HCl, pH 8 containing IM NaCl. 
A sample of VP secretion was centrifuged at 2000g for 30 min. Total 
protein in the supernatant was determined and the concentration was adjusted to 3 
mg/ml with 0.05M phosphate buffer, pH 7.4. After that, the VP secretion was 
loaded onto the sperm membrane protein-Sepharose 4B column, which had been 
equilibrated with 0.01 M Tris-HCl buffer (pH 7.4). Finally, the column was 
rinsed with phosphate buffer containing 0.5M NaCl to remove non-specifically 
bound proteins. Proteins bound specifically to sperm membrane were eluted with 
3M protassium thiocyanate (KSCN). The eluate which contained SBVPP was 
concentrated, dialyzed, lyopholized and stored at -70�C. 
2.2.3.3. FPLC Gel Filtration 
The affinity purified protein was fractionated with a Pharmacia Fast 
Performance Liquid Chromatography AKTA system. The proteins were dissolved 
in 0.2M PBS, centrifuged and loaded onto the prepared Superose 6 (10/30) 
column (Amersham Bioscience, Sweden) and eluted at a rate of 0.4 ml/min. The 
eluate was concentrated with Centricon-3 concentrator (Millipore, Billerica, MA) 
and stored at -70°C. The proteins were dissolved in lysis buffer and protein 
concentration was determined before loading the sample for electrophoresis. 
2.2.4. Histology of Flushed Uterus 
Samples of flushed uteri from section 2.2.2.2. were fixed, processed, 
sectioned serially and stained with Hematoxlin and Eosin (Appendix B) for 
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routine histological examination for integrity of the epithelium. The sections were 
examined with Axioplan Microscope at X400 (Zeiss, Germany). 
2.2.5. Quantification of Protein 
For protein profile comparison between samples, the same amount of 
protein must be loaded for electrophoresis separation; so a protein assay is 
essential. A protein assay kit based on the Bradford dye-binding principle 
(Bradford, 1976) purchased from Bio-Rad Laboratories, (Hercules, CA) was used. 
The assay was based on the color change of Coomassie Brilliant Blue G-250 dye 
binding to various quantities of protein. Procedure provided by manufacturer was 
adopted. Four different concentrations of proteins at 0.01, 0.02, 0.04 and 
0.06|ig/^l were used to plot a standard curve. The assay was performed on a 96 
wells plate, 160|LI1 of standard solution containing different concentrations of 
protein was added to each well. One lul protein extract from tissue was mixed with 
159}il water in each well. Forty jul dye reagent concentrate was added to each 
well, and the mixture was mixed thoroughly by pipetting up and down. 
Incubation at room temperature for at least 5 min, but no more than 1 hour 
followed. After incubation, absorbance was measured at 595nm by a V max 
kinetic microplate reader (Molecular Devices). Once the measurements were 
obtained, a standard cure was generated and the concentration could be calculated 
by using the EXCEL spreadsheet program (Appendix G). 
2.2.6. Two dimensional Electrophoresis 
Soluble proteins extracted from male ASG secretions, VP proteins 
specifically bound to sperm membrane (SBVPP) and protein extracted from 
female hamster uterine fluid flushing were analyzed by two dimensional 
electrophoresis which separated proteins by charge and molecular weight. At 
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least eight samples were analyzed for each experimental group. Analysis for 
SBVPP and different ASG secretions were repeated at least 5 times. 
2.2.6.1. First Dimension—Isoelectric Focusing 
Commercially available immobilized dry pH gradient strips (Amersham 
Bioscience, Sweden) were used for this experiment. They were 13cm in length 
and were of two pH ranges, i.e. 3-10 and 4-7. The strip was swollen by 
rehydration buffer containing 1% carrier amplolyte overnight at room temperature. 
During the rehydration process, the gel strip was kept face down and covered by 
mineral cover oil (Amersham Bioscience, Sweden) to prevent urea crystallization 
and drying. On the following day, the gel strip was placed on the strip holder face 
up. Small pieces of filter paper were placed at both ends of the strip and the 
electrodes were placed on top of them. Finally, the sample loading cup was 
placed on the gel strip between the two electrodes, care was taken to ensure that 
the feet of the sample loading cup rested on the bottom of the cup holder to 
prevent sample leakage. Once the sample loading cup was properly placed, 
sample was added. 290 ^g of protein sample was loaded for each analysis in a 
volume not exceeding 100|liL Before starting isoelectric focusing, mineral cover 
oil was added to cover each strip, and the strip holder was covered by the cover. 
The strip holder was placed on the platform of the Ettan IPGphor isoelectric 
focusing system (Amersham Bioscience, Sweden). The program was set as 
described in Appendix H. 
2.2.6.2. Second Dimension—SDS PAGE 
After lEF, the gel strip was processed for second dimension separation 
immediately. Our second dimension separation was performed on a HoeferTM SE 
600 RubyTM vertical system (Amersham Biosciences, Sweden). After first 
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dimension separation, the strip was soaked in equilibration buffer (Appendix B) 
with 0.5% Dithiothreitol (DTT) (USB Corporation, Cleveland, OH) for 30 min. 
After that, the strip was transferred to equilibration buffer that contained 0.5% 
lodoacetamide (I A A) and soaked for another 30 min. When equilibration steps 
were done, the strip was ready for SDS PAGE separation. The SDS gel was 
prepared as described in Appendix H. A 12% homogenous gel measuring 160mm 
X 160mm X 1mm was used. A 4% stacking gel layer was set on the top of the 
separating gel to form wells for standard marker and gel strip. 7\i\ molecular 
weight standard marker (Femanta Life Scinences, Lithuania) (Appendix F) was 
used for each run. Once the standard marker and strip were in place, the gel was 
sealed by 1% agarose (Appendix B). The electrophoresis condition was set at 
constant voltage (80V) and temperature (12°C) maintained by a Hoefer DC Power 
Supply (Hoefer Scientific Instruments, San Fransica, CA), and Multi Temp III 
circulator (Pharmacia Biotech, Sweden). Electrophoresis was terminated when 
the dye front reached the edge of the gel. During the initial migration and 
stacking period, the voltage was half of that required for the separation. 
2.2.6.3. Visualization of Protein Spots 
When the electrophoresis was done, the gel was removed from the 
cassettes and prepared for staining. All 2-DE gels generated in this study were 
stained with silver because it is the most sensitive non-radioactive method that can 
detect protein amount below lr|g. The left lower comer of the gel was cut to 
identify the acidic end. Staining procedure comprised four steps: fixation, 
sensitization, silver rinse, and development. 
The gel was soaked in fixation solution 1 for Ih, then washed with Milli Q 
water for 40 min with 2 changes. Sensitization was started by soaking in fixation 
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solution 2 for 10 min, then washed with Milli Q water for 1 h with 4 changes. 
After that, the gel was soaked in silver solution for 1 h at 4°C. After the silver 
rinse, the gel was briefly washed with Milli Q water and then developed with the 
developing solution for as long as necessary. Finally, the development of gel was 
terminated by stop solution. The gels were kept in Milli Q water before scanning. 
2.2.7. Identification of Proteins 
2.2.7.1. Protein Spots Detection 
All 2-DE gels generated in this chapter were scanned by Bio-Rad GS 800 
densitometer, and the 2-DE gels were analyzed by PDQuest 2-D analysis software 
(Bio-Rad Laboratories, Hercules, CA.). All gels were analyzed under the same 
detection setting. Only spots that consistently appeared on three gels were 
considered valid. After detection, the software automatically match spots within 
the same match set. Reference spots such as 2-D markers were matched manually. 
All pi values and molecular weights of the spots were estimated with reference to 
reference spots. Also, within the same match set, the gels were normalized with 
each others based on the total spots intensities of each gel. Finally, the pi value, 
molecular weight and intensity for each spot and the differences between groups 
were obtained by the analysis software. 
2.2.7.2. MALDI-TOF 
2.2.7.2.1. In-Gel Digestion for MALDI-TOF 
Selected 2-DE Gel spots from ASG secretion samples, uterine fluid 
samples collected 1 h after mating and sperm binding VPG protein were processed 
for in-gel digestion. The selected gel spots on each gel were manually cut out and 
placed in 0.5 ml microcentrifuge tubes. Before in-gel digestion, the silver was 
removed from the stained gel spots. Immediately prior to use 30mM potassium 
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ferricyanide and lOOmM sodium thiosulfate (Appendix D) was mixed in a 1:1 
ratio. The gel spots were soaked in 200 jul of this solution for 10 min or until the 
gel spots became clear; this step converted the silver to a water soluble form. The 
destaining solution was removed and the gels were washed with 200jLil Milli Q 
water for 45 min with 3 changes; this step washed away the soluble silver. After 
washing with Milli Q water, the gel spots were soaked in 200jLil 50% ACN/25 mM 
ammonium bicarbonate solution (Appendix D) for 45 min with 3 changes. Finally, 
the gel spots were dehydrated by 100% ACN for at least 5 min or until they turn 
opaque white. The tubes were uncapped and the ACN was removed. Finally the 
tube was covered with parafilm, and the gel spots were dried by UNIVAPO lOOH 
Speed-Vac (UniEquip, Germany) for 20 min, this step would shrink the gels. 
After the gel spots were cleaned and dried, they were ready for trypsin 
digestion. 20 jLil (200rig) cold working trypsin solution (Promega, Madison, WI) 
(Appendix D) was added to each gel spot. Care was taken to ensure that there was 
sufficient trypsin solution to completely wet the gels. The gels were swollen and 
became clear. Finally, the gels were incubated with trypsin at 37�C fori6-24 h. 
After enzymatic digestion, the following steps were carried out to extract the 
peptides. On the following day, the gels spots were soaked in 30 jul 50% ACN / 
50/0 TFA for 60 min. The supernatant was transferred to a clean 500 ml 
microcentrifuge tube, and the gel spots were extracted again with another SOjul 
50% / 5% TFA for 60 min. The two extracts were combined and lyophilized in 
Freezone® 12 freeze dryer. For MALDI-TOF analysis, the protein powders were 
reconstituted with 3 |li1 5% ACN / 0.1% TFA (Appendix D). 
2.2.7.2.2. MALDI-TOF Analysis 
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Digested proteins were analyzed by MALDI-TOF. The first step was to 
spot the digested protein on the MALDI sample plate (Applied Biosystem, Foster 
City, CA). To spot the sample, a matrix must be added to the sample. We used 
a-cyano-4-hydroxy-cinnamic acid (CHCA) as our matrix for all analyses. Two 
gram purified CHCA was dissolved in 1 ml 50% ACN/0.3 TFA solution 
(Appendix D) with agitation. The matrix solution was centrifuged for 20 sec to 
allow undissolved matrix to settle, the supernatant was ready for sample 
preparation. 1 |il sample was mixed with 1 jiil dissolved matrix, and then 1 jjJ of 
this mixture was pipetted into each well on the 100 wells MALDI sample plate 
(Applied Biosystem, Foster City, CA). A S e q u a z y e T M Peptide Mass Standards Kit 
purchased from Applied Biosystem (Foster City, CA) was used for calibration 
(Appendix F). 1 jul calibration mixture 1 was mixed with 24 jul matrix solution. 
1 jil of this mixture was pipetted into a well surrounded by other samples. 
MALDI-TOF analysis by a Voyager-DE™PRO Biospectrometry™ (Applied 
Biosystem, Foster City, CA) could proceed once the samples and the calibration 
mix were dried. For each analysis, the same laser intensity was used for all 
samples and calibration. For all samples, 20kV accelerating voltage and 70% grid 
voltage were applied; 1000 shots were accumulated to generate the spectrum. 
2.2.7.2.3. MALDI-TOF Data Analysis 
The Voyager Version 5 Software with Data ExplorerTM (Applied 
Biosystem, Foster City, CA) was used to process the spectra. Each spectrum 
generated a series of peptide masses. Based on these masses, pi value and 
molecular weight of the protein, the identity of the protein could be obtained from 
on-line databases. Protein Prospector 4.0.5 provided by University of California, 
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San Francisco (http://prospector.ucsf.edu/) was used in this study. The same 
search criteria listed on Appendix H were used in each search. 
2.2.8. Confirmation of Prostate Specific Antigen (PSA) 
PSA was confirmed by western blotting (Appendix J) on 2-D gels of 
SBVPP. The primary antibody used was rabbit anti-human prostate specific 
antigen (PSA) (Accurate Chemical & Scientific Corporation, Westbury, NY) 
diluted 1 to 1000. 
2.2.9. Confirmation of Prostatic Acid Phosphatase (PAP) 
PAP was confirmed by western blotting (Appendix J) on 2-D gels of 
SBVPP. The primary antibody used was rabbit anti-human prostatic acid 
phosphatase (PAP) (Sigma, St. Louses, MO) diluted 1 to 1000. 
2.2.10. Confirmation of Tumor Necrosis Factor Stimulated Gene-6 (TSG-
6) 
Tumor necrosis stimulated gene-6 (TSG-6) initially found in Ih p.c. 
uterine fluid flushing was confirmed by polymerase chain reaction (PGR) 
(appendix L). RNA was extracted from 1 h p.c. uterine tissue according to 
protocol described in appendix I. The RNA was conversed to mRNA by reverse 
transcript-polymerase chain reaction (RT-PCR) (Appendix K). Primers were 
designed by using the online database-Primer 3 based on the conserved regions 
found in mouse and human sequences. The primers were synthesized by 
Invitrogen Biotechnology, Hong Kong. Primer pairs were: sense: 5，-TTT GCT 
TAT GCG TCT TGC TG-3,, antisense: 5,-GAC GGA TGC ATC ACT CAG AA-
3,. p-actin sense: 5,-A丁G GAT GAC GAT ATC GCT GCG-3', antisense: 
5’-CTA GAA GCA TTT GCG GTG GAC-3' was co-amplified as internal control. 
lOjil PGR product was mixed with l[i\ 6X loading dye and run on 2% agrose in 
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0.5X TBE buffer at constant 70V for one hour. The agrose gel was then stained 
with 0.1% ethidium bromide (EB) (Appendix E). The amplicons were visualized 
by an UV transilluminator (FluorChem TH 8000, Alpha Innotech Corporation, 
San Leandro, CA). Sequence of the PGR product with the predicted size was 
analyzed by DragonTech Ltd, Hong Kong, a commercial DNA sequencing service. 
Finally, the sequence was matched with the existing mouse and human sequence 
by Blast for homology. 
2.2.11. Scanning Electronic Microscopy (SEM) 
The 1 and 4 h p.c. uteri were removed as described in section 2.2.2.2.. 
Both ends of the uterus were tied up. Then it was prefixed with 2.5% and 2% 
paraformaldehyde in 0.1 M cacodylate buffer (0.1 M phosphate buffer, pH 7.4). 
After 2 h, the uterus was cut in half and then continues the fixation for another 4 h 
at 4°C. After the fixation, the uterus was washed in 0.1 M cacodylate buffer 
(O.IM phosphate buffer) for several times. The uterus was then postfixed in 1% 
osmium tetroxide for 2 h at room temperature. After postfixation, the uterus was 
washed with 0.1 M cacodylate buffer for 3 times. Then the uterus was dried in a 
graded series of ethanol and by using the high pressure dryer (LADD research 
industries). Dried uterus was mounted on aluminum stubs and coated with a thin 
film of gold-palladium. Finally the uterus was examined 4-5 kV with SEM (JSM-
630IF scanning electronic microscopy, JEOL, Japan) to visualize the physical 
condition of the sperm within the uterine horns. 
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2.3. Results 
2.3.1. Morphology of Flushed Uteri 
To prove that the endometrial epithelium remained intact after the flushing 
procedure and release cells in our uterine fluid flushing samples, samples were 
randomly selected for histological examination after hematoxylin and eosin 
staining. No significant damage was found at X400 magnification (Fig. 2-1). 
2.3.2. Protein Concentration 
Protein concentrations of uterine fluids from different groups collected at 1 
and 4hp.c. were measured. Table 2-1 summarizes the results. The concentration 
for 1 hp.c. uterine fluid flushing were 4.50±0.36, 4.08±0.39 and 4.25±0.37 mg/ml 
for SH, VPX and TX respectively. The mean concentration for 4 hp .c . uterine 
fluid flushing were 5.83士0.33, 4.74土0.22 and 4.96士0.28 mg/ml for SH, VPX and 
TX respectively. In all three groups, the protein concentration for Ah p.c. uterine 
fluid flushing was higher than 1 \ip.c. sample. Data was analyzed Student's t-test; 
P<0.05 for within time point comparison of SH, VPX and TX. No significant 
difference is found in 1 hp .c . uterine fluid flushing protein concentration in the 
three groups. However, the protein concentration in SH 1 h p.c. uterine fluid 
flushing is significantly higher compare to VPX and TX groups. 
2.33. Serum, Pre and Post Coital Uterine Fluid Protein Profiles 
Soluble proteins in serum, day 2 uterine fluid flushing and SH 1 h p.c. 
uterine were separated by 2-D electrophoresis. Representative pH 3-10 two 
dimensional gels of serum, day 2 and SH 1 hp.c. uterine fluid flushing are shown 
on Fig. 2-2; data are summarized in Table 2-2. A 2-D gel profile comparison of 
serum, day 2 and SH 1 h p.c. sample were made. 188 spots were detected in 
serum, 236 spots were detected in day 2 and 322 spots were detected in SH Ihp.c. 
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sample. Result shows that 12 spots and 18 spots in day 2 and SH 1 hp.c. sample 
were serum proteins respectively. 31 spots matched in day 2 and SH 1 h p.c. 
uterine fluid flushing, which means 31 pre-coital proteins remained in post coital 
uterine fluids. Six spots were found in all three groups, this indicated that some 
serum proteins appear in both pre and post coital uterine fluids and include 
albumin and transferrin. 
2.3.4. ASG secretory Proteins and Their Fate After Mating 
After mating, the ASG secretory proteins in the uterine lumen may interact 
with each other or with uterine secretory proteins or bind to the sperm. 
2.3.4.1. ASG secretory Proteins and 1 hp.c. Uterine Fluid 
ASG secretory proteins were separated by 2-D electrophoresis. 
Representative pH 3-10 two dimensional gels of secretory proteins from the five 
different ASG (VP, DP, AG, CG, and SV) and SH 1 hp.c. uterine fluid flushing 
are shown on Fig. 2-3; and Table 2-3. A 2-D gel profile comparison of ASG and 
SH Wip.c. sample was made. 322 spots were detected in SH Ihp.c. sample. 192, 
396, 312, 197, and 39 spots were detected in VP, DP, AG, CG, and SV 
respectively. Among those spots, 32 (16%) spots from VP, 28 (7%) spots from 
DP, 25 (8%) spots from AG, 12 (6%) spots from CG, and 9 (23%) spots from SV 
were matched with SH 1 hp.c. uterine fluid flushing sample. 
2.3.4.2. VP Secretory Proteins and SBVPP 
Some VP secretory proteins were found specifically bound to sperm 
membrane by affinity chromatography. The SBVPP were further purified by gel 
filtration. SBVPP were separated by 2-D electrophoresis with lEF of pH 3-10 two 
dimensional gels of secretory proteins from the VP and SBVPPs was shown on 
Fig. 2-4 and Table 2-4. A 2-D gel profile comparison of VP and SBVPP were 
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made. 192 spots were detected in VP secretion and 176 spots were detected in 
SBVPP sample. Among those spots, 138 spots were found in both groups. 
Eleven proteins spots (Fig 2-5) from SBVPP were identified by MALDI-
TOF. The representative spectra of identified proteins are shown on Fig. 2-6. The 
proteins includes: albumin, Transferrin, Brevican, Angiopoietin 1, Hepatoma-
derived growth factor, Kallikrein 10, Kallikrein 4, Neuroglycan C, Dentin matrix 
acidic phosphoprotein, Mannan-binding lectin serine protease 1 and 
Thrombospondin 4. The MOWSE score, percentage of peptide matched/peptide 
total, accession number, observed molecular weights/pl, and theoretical molecular 
weights/pl of each protein were listed in Table 2-5. 
2.3.4.3. PAP and PSA 
In addition, two proteins were found to immunoreact with was rabbit anti-
human prostatic acid phosphatase (PAP) (Fig. 1-1K) and rabbit anti-human 
prostate specific antigen (PSA) (Fig. 2-7B). The former had an estimated pi of 
4.5 and a molecular weight of 60k Da. The latter had a pi of 4.3 and a molecular 
weight of 31kDa. 
2.3.5. Protein Profiles at 1 h p.c. 
Protein in 1 h p.c. uterine fluid flushing were separated by 2-D 
electrophoresis. They were focused in two pi ranges in the first dimension (lEF). 
Representative pi 3-10 two dimensional gels for SH, VPX and TX are shown in 
Fig. 2-8. Summary and Venn diagram are shown in Fig. 2-9. There were 322, 
452 and 402 spots in SH, VPX, and TX respectively. Amongst those spots, 75 
were common to all groups; 155 spots were detected in SH and VPX only; 128 
spots were detected in VPX and TX only; and 180 spots were detected in SH and 
TX only. Of the shared spots between SH and VPX, 52 spots are up-regulated 
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and 103 spots are down-regulated. Of the shared spots between SH and TX, 62 
spots are up-regulated and 118 spots are down-regulated. Representative pH 4-7 
two dimensional gels are shown in Fig. 2-10. Summary and Venn diagram are 
shown in Fig. 2-11. In this set of analysis, 242, 343 and 213 spots were detected 
in SH, VPX, and TX respectively. Among those spots, 119 spots were detected in 
all groups; 181 spots were detected in SH and VPX only; 123 spots were detected 
in VPX and TX only; and 137 spots were detected in SH and TX only. Of the 
shared spots between SH and VPX, 57 spots are up-regulated and 114 spots are 
down-regulated. Of the shared spots between SH and TX, 50 spots are up-
regulated and 87 spots are down-regulated. 
2.3.6. Protein Profiles at 4 h p,c. 
Protein in 4 h p.c. uterine fluid flushing were separated by 2-D 
electrophoresis. They were focused in two pi ranges in the first dimension (lEF). 
Representative pH 3-10 two dimensional gels for SH, VPX and TX are shown in 
Fig. 2-12 and Fig. 2-13. There were 331, 255 and 226 spots in SH, VPX, and TX 
respectively. Amongst those spots, 74 spots were detected in all groups; 139 spots 
were detected in SH and VPX only; 99 spots were detected in VPX and TX only; 
and 115 spots were detected in SH and TX only. Of the shared spots between SH 
and VPX, 58 spots are up-regulated and 81 spots are down-regulated. Of the 
shared spots between SH and TX, 47 spots are up-regulated and 68 spots are 
down-regulated. Representative pH 4-7 two dimensional gels are shown in 
Fig. 2-14 and Fig. 2-15. In this set of analysis, 555, 428, and 432 spots were 
detected in SH, VPX, and TX respectively. Among those spots, 139 spots were 
detected in all groups; 167 spots were detected in SH and VPX only; 144 spots 
were detected in VPX and TX only; and 182 spots were detected in SH and TX 
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only. Of the shared spots between SH and VPX, 55 spots are up-regulated and 
112 spots are down-regulated. Of the shared spots between SH and TX, 72 spots 
are up-regulated and 110 spots are down-regulated. 
2.3.7. Identification of Proteins Differentially Expressed by the Three 
Groups at 1 h p,c. 
Fourteen differentially expressed proteins were identified from 1 h post 
coital uterine fluid flushing. The MOWSE score, percentage of peptide 
matched/peptide total, accession number, observed molecular weights/pl, and 
theoretical molecular weights/pl of each protein were listed in Table 2-6. The 
spot intensities bar chart and magnified spots for the three groups were shown on 
Fig 2-6. 
These protein spots were successfully identified by MALDI-TOF analyzes. 
Representative spectra of identified spots were shown on Fig. 2-17. Those 
proteins included hyaluronidase (HYAL2), cysteine rich protein 61, angiopoietin 
2, small inducible cytokine subfamily E, interleukin 12b p40 subunit, tumor 
necrosis factor alpha induced protein 6 (TSG-6), androgen binding protein alpha, 
prostatic steroid-binding protein chain CI precursor, C lectin-related protein A, 
interleukin 1 receptor antagonist, Clr-like protein, prostate spermine-binding 
protein precursor (SBP), lympotactin and brain-derived neurotrophic factor. 
2.3.7.1. Confirmation of TSG-6 
RT-PCR was used to confirm MALDI-TOF identified proteins. At Ih 
after mating, the combination of laser densitometry and MALDI-TOF analyzes 
indicated that TSG-6 is up-regulated in uterine fluid collected from VPX group 
compared with the SH control The presence of TSG-6 in 1 h and 4 h p.c. uterine 
tissues was confirmed by RT-PCR (Fig.2-18). The PCR product sizes for all six 
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samples (two time points for three experimental groups) were around 700bp; and 
the predicted PGR product size for the specific primer pairs were 692bp. For co_ 
run (3-actin primer pairs, the PGR product sizes for all six samples were around 
llOObp; and the predicted PGR product size for the specific primer pairs were 
1128bp. Fig. 2-19 showed that the partial nucleotide sequence of the PGR product 
was 89% homologous to that of tumor necrosis factor alpha induced protein 6 of 
the mouse {Mus musculus). On Fig 2-20, the hamster TSG-6 sequences was 
compared with human and mouse sequences; the unshadowed part indicated the 
unmatched nucleotides. 
2.3.8. SEM 
Scanning electronmicrographs of uterine content at \hp.c. from SH group 
and VPX group at 6500 X magnification are shown in Fig 2-21; at 10000 X 
magnification is shown in Fig. 2-22. As shown on the picture, more protein was 
found in VPX group sample. 
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2.4. Discussion 
In this chapter, we have investigated the temporal differences of protein 
concentration in post-coital uterine fluid flushing. Proteomic techniques such as 
2-D electrophoresis and MALDI-TOF are used to identify proteins from serum, 
SBVPP, A S G secretions and pre and post-coital uterine fluid flushings. TSG-6 
presents in 1 and 4 h post-coital uterine fluid and it m R N A expression is found in 
the uterine tissue by RT-PCR. Also, protein expressions of serine proteases such 
as PSA and PAP found to specifically bind to sperm. 
The results presented in this study demonstrate that there is a temporal 
change in post-coital uterine protein concentration. The amount of soluble 
proteins present in post-coital uterine fluid is determined by several factors: (1) 
proteins secreted by uterus, (2) proteins from seminal plasma (ASG), (3) proteins 
from proteolysis of clotted seminal plasma and (4) proteins from degraded sperm. 
The uterine fluid flushing protein concentration is evaluated at 4 h after mating in 
the SH, V P X and T X groups (Table 2-1). In both 1 h and 4 hp.c. uterine fluid 
flushing, the protein concentrations in V P X and T X groups are lower compared 
with SH group. This can be due to the decreased volume of seminal plasma and 
other indirect systematic effect in the uterus. However, when comparing the 
protein concentration between two time points; the protein concentrations of 4 h 
P.c. uterine fluid flushing for the three groups are higher than \hp.c. uterine fluid 
flushing. This can be attributed to degradation product of sperm as soluble 
proteins only are analyzed in the present study. Within 2 h of insemination, 85-
90o/o of the deposited sperm can not be found in female reproductive tract of cattle 
and sheep (Lightfoot and Restall, 1971; Dobrowolski and Hafez, 1970; El-Banna 
and Hafez, 1970). In pig, large numbers of spermatozoa are lost due to 
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phagocytosis by polymorphonuclear leukocytes (PMNs). The recruitment of 
P M N s to the uterine lumen appears to be triggered by insemination of a volume of 
liquid, rather than by specific components of that liquid or by spermatozoa or 
seminal plasma. However, persistence of large numbers of P M N s in the uterine 
lumen at > 12 h after insemination appears to depend on the presence of 
spermatozoa in the inseminate. In vitro studies have indicated that damaged, 
killed or capacitated spermatozoa are not phagocytosed preferentially, but that 
capacitation treatment strongly reduced phagocytosis of spermatozoa (Woelders 
and Matthijs, 2001). Therefore, degradation of sperm may release the intra-
cellular protein into the uterine environment. The higher protein concentration in 
the SH group may be due to (1) larger ejaculate volume, (2) more proteolysis of 
clotted proteins and (3) more sperm. In the V P X group, a large amount of A S G 
(seminal plasma) protein remains insoluble because VP secretion contains a lot of 
proteases. 
Results from serum, day 2 and SH 1 h post coital uterine fluid 2-D gels 
demonstrate that some serum proteins are constituents of both pre and post-coital 
uterine fluids. Six proteins including albumin and transferrin are found in all three 
groups in both pre and post-coital uterine fluid, which means that seminal plasma, 
in particular, its contained enzymes does not affect these serum proteins in the 
uterine fluid. Many more protein spots are presented in post-coital uterine fluid as 
compared to pre-coital uterine fluid. It will useful to follow the fate of these 
proteins for possible application in forensic medicine, especially when the 
presence of sperm is not apparent. 
Secretory proteins from five different ASGs were matched with proteins 
present in 1 h post-coital uterine fluid. The sperm and A S G secretions may be 
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removed by endocytosis and phagocytosis within the first hour after mating. This 
set of data demonstrated that within one hour after mating, the A S G secretory 
proteins remain intact. 16 and 23% of VP and SV secretory proteins remain in the 
uterus lumen at 1 h post coiutm; while only 7%, 8% and 6 % of DP, A G , and C G 
secretory proteins are left. In term of percentage, VP and SV secretory proteins is 
three fold the amount that DP, A G and C G secretory proteins that remain in the 
uterine lumen at 1 h post coiutm. Since by volume SV contributes about 70 % of 
the seminal plasma, it is reasonable that more time is needed to totally remove the 
SV secretory proteins from the uterus. Other the other hand, the low reprentation 
of A G may be due to relatively low protein content in the A G secretion. In rodent, 
the major function of C G is to secrete transglutaminase to coagulate protein from 
SV to form vaginal plug (Williams-Ashman, 1984), so it is reasonable that only a 
small amount of proteins is remains in the uterine fluid. Previous study has also 
proven that interactions of A S G secretions and spermatozoa were complicated by 
the presence of uterine secretions, both uterine and A S G secretions could modify 
proteins on the sperm membrane (Cheng et al, 1995). Similar modification of 
A S G secretory protein may happen in the uterine fluid after mating. 
VP secretory proteins may bind to the sperm membrane upon ejaculation 
or form a component of uterine fluid after mating. A comparison of 2-D profiles 
of VP secretory proteins and SBVPP shows that 72% of VP protein spots matches 
with those in SBVPP, which means that 72% VP proteins specifically bind to the 
epididymal sperm membrane in our in vitro study. Since majority of VP secretory 
proteins are bound to the sperm membrane, it also explains why only small 
portion (16%) of VP secretory proteins is found in Ihp. c. uterine fluid. 
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Proteins that immunoreact with prostatic acid phosphatase (PAP) are 
found in SBVPP (Fig.2-20A). PAP is an enzyme in human seminal plasma that 
cleaves synthetic peptidyl substrates derived from sequence of human 
semenogelins (Brillard-Bourdet et al., 2002). PAP m R N A intensely expresses in 
epithelial cells of the human prostate gland after puberty (Shan et al., 2003). 
Individuals 36 years and above with very severe oligospermia have sperm counts 
and motility positively correlated to level of PAP (Singh et al., 1996). PSA and 
PAP share some common properties. The binding of PAP to epididymal sperm 
may increase the proteolysis of uterine luminal matrix and free the sperm for 
better motility. 
Immunoreactivity againsts prostate specific antigen (PSA) is found in 
SBVPP (Fig.2-20B). Different mass values of PSA has been published in the 
literature, with estimates ranging from 26,079 (without the carbohydrate moiety) 
to 34,000 Da (Sensabaugh 1978; Wang et al., 1979; Watt et al., 1986; Schaller et 
al, 1987; Graves et al., 1993; Graves et al., 1990). These values are estimated by 
SDS-PAGE, amino acid sequencing or gel filtration. In this study, we estimate 
that the mass of hamster PSA is 31kDa, and it falls into the range of published 
values. Insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) is a major 
serum carrier protein for the IGF and is found in seminal plasma (Cohen et al., 
1992). PSA is a serine protease found in seminal plasma as well, and it cleaves 
EGFBP-3. Cohen et al., (1992) speculates that PSA may serve to modulate IGF 
function within the reproductive system. It is because the cleavage of IGFBP-3 by 
PSA results in a marked reduction in binding affinity of the fragments of IGF-I, 
but not IGF-II. In human semen, PSA digests the gel proteins semenogelin I and 
II, resulting in liquefaction and the release of motile spermatozoa (Henttu and 
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Vihko, 1994). Seminal viscopathy and sperm motility were shown to be 
associated with male infertility. The concentration of PSA was significantly lower 
in hyper-visco-elastic semen samples (ELzanaty et al., 2004). Another study 
shows a direct correlation between the seminal PSA levels and sperm motility in a 
group of men. Sperm motility was assessed by a manual method as well as 
computer-assisted sperm analysis (CASA); and values are correlated to seminal 
levels of PSA. The result shows that the level of PSA was the most significant 
independent parameter in predicting percentage of motile sperm (Elzanaty et al, 
2002). 
Based on this study, we conclude that PAP and PSA bind to the sperm 
membrane may increase their ability to cleave uterine fluid matrix proteins and 
help them to clear the proteins which block their way inside the female 
reproductive tract. Increased motility is important for sperm too and the 
membrane proteins help the sperm to move faster toward the oviduct and fertilize 
the oocyte. Our S E M result also supports this conclusion. As the micrographs 
show, the ablation of VP associated with more uterine matrix proteins inside the 
uterine lumen. The uterine matrix proteins block/bind to sperm and prevent them 
from moving toward to the oviduct. 
Kallikrein 4 (KLK4) is also identified in SBVPP by MALDI-TOF 
(Fig. 2-6). KLK4 is a serine protease that belongs to a highly conserved 
multigene family—tissue kallikrein which is important in post-translational 
processing events. Although KLK4 is missing a "kallikrein loop" region, KLK4 
still encodes a 254-amino acid prepro-serine protease that is 78% identical to pig 
enamel matrix serine protease and 〜370/0 identical to PSA, tissue kallikrein, and 
the K2 enzyme (Sally et al., 1999). KLK4 sequences for pig (Simmer et al, 
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1998), mouse (Hu et al., 2000), and human (Simmer et al., 2000) have already 
been coded. In human prostate, KLK4 m R N A is expressed in normal and 
neoplastic prostate epithelial tissues, but not by prostate stromal constituents 
(Nelson et al, 2001). In human and many mammalian species, a seminal clot 
formed almost instantaneously after mating. It dissolves within minutes to release 
motile sperm. Such process is likely to involve precursor or zymogen activation. 
Many proteases are synthesized and secreted as inactive forms called zymogens 
which subsequently are activated by proteolysis. Zymogen such as KLK4 
requires limited proteolysis for its activation. Because they are trypsin-type serine 
proteases, they are all potential activators of PSA (Thomas et al., 2001). Another 
potential role of serine proteases in prostate biology is the regulation of PAP. A 
previous study demonstrated that recombinant KLK4 readily degrades PAP in a 
dose-dependent manner (Thomas et al., 2001). Since KLK4 can potentially 
activates PSA and degrades PAP, we believe that K L K 4 may bind to sperm 
membrane together with PSA and PAP and modulate them. 
Kallikrein 10 (KLKIO) is identified in SBVPP by MALDI-TOF (Fig. 2-6). 
The human K L K 10 gene is also known as normal epithelial cell-specific 1 gene 
(NESl) (Luo et al., 2001). The main immunoexpression sites for KLKIO are 
glandular epithelia such as breast, prostate, kidney, epididymis, endometrium, 
fallopian tubes, gastrointestinal tract, bronchus, salivary glands, bile ducts and 
gallbladder (Petraki et al., 2002). The gene encodes for a 30kDa serine protease 
(hKlO) made up of 276 amino acids and is predicted to have trypsin-like 
enzymatic activity (Liu et al., 1996). Recent study shows that the KLKIO 
expression is regulated by estrogens, androgens and prgestins in breast cancer cell 
lines, both at the m R N A and protein levels (Luo et al., 2003). The function of 
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K L K 10 is not well known. The K L K 10 that binds to epididymal sperm 
membrane may have trypsin-like activity. This activity may help the sperm to 
move towards the oviduct as PSA and PAP. 
At 1 h after mating, uterine proteins may be constituted by both uterus and 
seminal plasma proteins. To establish a successful pregnancy, interactions 
between semen and uterus are very important. Once the semen enters the uterus, 
the uterine environment start to change. Our data shows that there is considerable 
interaction between seminal plasma and the fluid in the uterine lumen. 
In both pi 3-10 and 4-7 gels of Ih p.c. uterine fluid flushing among the 
three groups; the largest numbers of spots are detected in V P X group. This result 
indicates that more variety of proteins is found in uterine fluid from female has 
mated with a VP removed male. This result can be explained by inflammatory 
responses by the uterus. Since the factors in seminal plasma may suppress the 
inflammatory responses, deletion of VP or all major A S G may result in more 
endocrine secretions and it lead to a higher numbers of detected proteins. Many 
of VP secretory proteins have proteolytic activity. Ablation of VP may hamper 
digestion of uterine matrix proteins which may in turn increase the variety of spots 
found in V P X group uterine fluid. 
The numbers of shared spots between V P X and T X groups are the least 
among three compared groups (SH and VPX, SH and TX) in both pi ranges. The 
result points out that partial and entire omission of the A S G secretions does lead 
to difference in protein profiles of uterine fluid at 1 h post coitum. There may be a 
correlation between different ASGs and the uterus. Cheng's (1995) previous 
study has also proven that interactions of A S G secretions and spermatozoa were 
complicated by the presence of uterine secretions. W e believe that the uterine 
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fluid may change according to the components in the seminal plasma. Also, these 
changes may be a long term systematic changes that will influence the embryo 
implantation at the later stage of pregnancy. 
The deletion of all A S G decreases the acidic protein secretions in the 
uterine fluid at 1 h post coitum. For the T X and V P X groups, more proteins spots 
are detected in pi 3-10 compared with control. However, for pi 4-7, less protein 
spots are detected in T X group compared with SH. Of the matched spots in both 
match sets, more spots are down-regulated in V P X and T X groups compared with 
SH group. The cause and significance of this phenomenon warrant more study. 
At 4 h post coitum, the uterine proteins may be constituted by both uterus 
and degradation of sperm. In both pi 3-10 and 4-7 groups, the biggest numbers of 
spots are detected in SH group, and followed by VPX. 
One of the functions of seminal plasma is sperm transportation. A large 
volume of seminal plasma helps to carry sperm rapidly to the uterotubal junction 
by distending the uterine lumen and the initiating smooth muscle contraction 
(reviewed by Suarez, 2002). In hamster, previous study also shows that the total 
removal of all A S G resulted in significantly fewer sperm reaching the oviduct at 
1.5 h post coitum (Chow and O, 1989). However, the data obtain from our group 
shows that removal of ventral prostate has no significant effect on the number of 
sperm recovered at various parts of the female genital tract. Less numbers of 
sperms found in female uterus in T X group may result in decreasing number of 
degradation sperm in the uterus at 4 h post coitum. Consequently, the protein 
concentration in uterine fluid flushing may also decrease. 
The numbers of shared spots between V P X and T X groups are also the 
least among three compared groups (SH and VPX, SH and TX) in both pi ranges. 
52 
The result points out that partial and entire omission of the A S G secretions does 
induce different protein secretions in the uterus at 4 h post coitum. The situation 
is the same as the 1 \ip.c. sample. There may be a correlation between different 
ASGs and the uterus. It seems without the stimulation by A S G secretion, the 
uterus may respond more like the control. Conversely, without VP secretion alone, 
the uterus may respond in a more different way. This finding may explain why 
removal of VP may reduce the fertility in hamster while total removal of A S G 
doesn't. This indicates that VP secretory protein may play a more important role 
in post coital uterine fluid and even for the implantation process. 
Also, the deletion of VP decreases the acidic proteins in uterine fluid at 4 h 
post coitum. For both pi ranges, the largest number of spots are detected in SH 
group. For the V P X group, more proteins spots are detected in pi 3-10 compared 
with TX; however, less protein spots are detected in pi 4-7 compared with TX. Of 
the matched spots in both match sets; more spots are down-regulated in V P X and 
T X groups compared with SH group. Similar to the situation at 1 ]ip.c., the cause 
and significance of this phenomenon need further investigation. 
The expression of tumor necrosis factor alpha induced protein 6 (TSG-6) 
is up-regulated in 1 h post coital uterine flushing from V P X group. TSG-6 is a 
cytokine-inducible gene product. It is important in inflammation and infection, 
also plays essential roles in female fertility。Recent evidence indicates that TSG-6 
and TSG14 are also essential components of the cumulus cell-oocyte complex 
(GOC) and that targeted deletion of either TSG-6 or TSG-14 gene causes female 
infertility (Varani et al, 2002; Fulop et al., 2003). The later work concluded that 
TSG-6 has a role in C O C matrix formation (Carrette, et al., 2001). Several other 
findings followed that supported the role of TSG-6 in C O C expansion. TSG-6 
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expression in cumulus cells is dependent on cyclooxygenase-2 (COX-2) and the 
prostaglandin E2 (PGE2) and receptor of prostaglandin E2, both known to be 
important in C O C expansion (Ochsner et al., 2003). 
The TSG-6 m R N A expression in C O C is quickly up-regulated after the 
administration of the ovulatory stimuli (gonadotropin from pregnant mare's serum, 
followed by human chorionic gonadotropin (hCG)) (Mukhopadhyay et al., 2001). 
Yoshioka et al (2002) also shows that TSG-6 expression is up-regulated in rat 
ovaries in response to ovulatory dose of hCG. hCG administration leads to 
endothelial activation regardless of the degree of ovarian response (Orvieto et al., 
2000). Endothelial activation is attributable to the ovarian response; it may 
suggest that TSG-6 stimulated by systematic effect. The TSG-6 expressions were 
found in several parts of female reproductive tract. In this study, we have 
demonstrated the presence of TSG-6 m R N A expression in hamster post-coital 
uterus. TNF-a m R N A is abundant on day 1 post coitum, reduced on day 2 and 
remained basal throughout the remainder of the preimplantation period in mice 
uterus (McMaster et al., 1992). Previous study shows that cytokine such as TNF-
a does have detrimental effects on implantation, trophoblast proliferation, 
embryo development and fetal survival (Shaarawy and Nagui, 1997). In the same 
study, it is also suggested that a potential mechanism of immunologic recurrent 
abortion may involves the secretion of TNF-a by endometrial lymphocytes and 
macrophages under influence either trophoblast or sperm antigens, and these 
cytokines could partially diffuse or penetrate into the systemic circulation 
(Shaarawy and Nagui, 1997). W e believe that expression up-regulated in TSG-6 
in V P X 1 h p. c. uterine fluid may due to the increase in TNF-a. The increase of 
TNF-a may be induced by presence of sperm. 
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2.5. Conclusion 
In this chapter, we have proven that: 
1. Some soluble proteins are shared by serum, pre and post coital uterine 
fluid, eg. Albumin, transferrin. 
2. At ejaculation 72% of VP secretory proteins specifically bind to sperm 
membrane and 16% are left in post coital uterine fluid flushing for at least 
one hour after maing. 
3. PSA, PAP, KLK4 and K L K 10 are bound to sperm membrane. 
4. The post coital uterine protein profiles are different in SH, V P X and T X 
groups. 
5. TSG-6 is up-regulated in V P X group in 1 h post coital uterine fluid 
flushing; it may due to the increasing amount of TNF-a produced in the 
presence of semen. 
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Legends and Figures 
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Table 2-1 
Protein content of uterine fluid flushings. Sample are collected by flushing 
the two uterine horns with 1 ml PBS with protease inhibitor at 1 or 4 h after 
mating. The female mate with males from SH, V P X and T X male groups. 
Protein Concentration 
^ h after 
Group mating ^ Mean (mg/ml) Range (mg/ml) 
” ~ Ih 10 4.50±0.36 3.98-4.91~ 
o n 
4h 8 5.83±0.33 5.26-6.45 
V P X Ih fO 4.08±0.39 3.33-4.63 
4h 8 4.74±0.22 4.51-5.10 
T X ^ 8 4.25±0.37 3.65-4.70~ 
4h 8 4.96±0.28 4.46-5.25 
N: Number of Animals 
57 
Fig. 2-1 
Representative histological section of flushed 1 h post coital uterus. The uterus 
section is stained with Hematoxlin and Eosin. The section is examined by 
microscope under different magnifications A) lOOX and B) 400X. No significant 
damage is found on the flushed uterine epithelium. (Ep: epithelium, Lu: lumen, St: 
stroma, BV: blood vessel and My: myometrium). 
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Representative two Dimensional Electrophoresis profiles of 1 h post coital uterine 
fluid flushings from SH group and day 2 (D2) virgins as well as serum from day 2 
virgins. The proteins are first separated on a 13 cm immobiline dry strip, pi 3-10 and 
then by a 12 % homogenous SDS-PAGE. Finally the protein spots are visualized by 
silver staining. The spots on three gels are matched and analyzed by PDQuest 
software under predetermined matching criteria. Details are described in Materials 
and Methods. Data are summarized in Table 2-2. Some of the matched spots are 
highlighted. Red circles represent those common for the three groups; blue circles 
represent spots shared by D2 and serum; purple circles represent spots shared by SH 
1 h uterine fluid flushing and D2; green circles represent spots shared by SH 1 h 
uterine fluid flushing and serum 
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Summary of protein spots detect on 2-DE gels of female hamster serum, 
day 2 uterine fluid flushings and 1 h post coital uterine fluid flushings from 
SH group. The table also shows the matching results for these three gels 
Gel # of Spots Matched with Matched with 
Detected Day 2 female serum 
Female serum 188 12 — 
Day 2 236 -- 12 
Ihp.c. S H 322 31 18 
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Fig. 2-3 
Representative two Dimensional Electrophoresis profiles of 1 h post coital uterine 
fluid flushings from SH group and secretions from ventral prostate (VP), dorsal 
prostate (DP), ampullary gland (AG), coagulated gland (CG) and seminal vesicle 
(SV). The proteins are first separated on a 13 cm immobiline dry strip, pi 3-10 and 
then by a 12 % homogenous SDS-PAGE. Finally the protein spots are visualized by 
silver staining. The spots on six gels are matched and analyzed by PDQuest 
software under predetermined matching criteria. Details are described in Materials 
and Methods. Data are summarized in Table 2-3. 
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Summary of protein spots detect on 2-DE gels of five 
different A S G secretions. The table also shows the number 
of spots in A S G secretions which match with SH group 1 h 
post coitus uterine fluid flushing. 
Gland Number of Spots Matched with 
Detected Ihp.c. SH (%) 
V P 192 32(16) 
D P 396 28 (7) 
A G 312 25 (8) 
C G 197 12(6) 
SV ^ 9 (23) 
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Fig. 2-4 
Representative two Dimensional Electrophoresis profiles of ventral prostate (VP) 
secretion and VP proteins specifically bound to epididymal sperm membrane 
(SBVPP). The proteins are first separated on a 13 cm immobiline drystrip, pi 3-10 
and then by a 12 % homogenous SDS-PAGE. Finally the protein spots are 
visualized by silver staining. The spots on two gels are matched and analyzed by 
PDQuest software under predetermined matching criteria. Details are described in 
Materials and Methods. Data are summarized in Table 2-4. Blue circles represent 
those common for the VP and SBVPP gels. 
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Table 2-4 
Protein spots detect on 2-DE gels of ventral prostate 
secretion and VP proteins specifically bound to epididymal 
sperm membrane (SBVPP). The table also shows the 
number of spots that common to the two gels. 
Qei Number of Spots Matched 
Detected Spots (%) 
192 138(72) 
SBVPP 176 138 (78) 
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Fig. 2-5 
Representative two Dimensional Electrophoresis profile of VP proteins specifically 
bound to epididymal sperm membrane (SBVPP). The proteins are separated by 
2-D electrophoresis as described in Materials and Methods. The eleven spots are 
highlighted. These spots are identified by MALDI-TOF analysis. 
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Representative spectra obtain from MALDI-TOF analysis. The protein spots are 
picked from VP proteins specifically bound to epididymal sperm membrane 
(SVBPP). Each protein spot is digested by Trypsin overnight, mixed with matrix 
and placed on sample plate for analysis. Each peak on the spectrum represents a 
single digested peptide, and the mass of it is shown on the top. The eleven identified 
proteins includes: 1) albumin, 2) Transferrin, 3) Brevican, 4) Angiopoietin 1 
(Ang-1), 5) Hepatoma-derived growth factor (HGDF), 6) Kallikrein 10 (KLK 10), 7) 
Kallikrein 4 (KLK 4), 8) Neuroglycan C, 9) Dentin matrix acidic phosphoprotein, 
10) Mannan-binding lectin serine protease 1 and 11) Thrombospondin 4. 
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The VP proteins specifically bound to epididymal sperm membrane (SBVPP) are 
purified by FPLC and gel filtration. The purified proteins are separated on a 13 cm 
immobiline dry strip, pi 3-10 and then by a 12 % homogenous SDS-PAGE. After 
2-D electrophoresis, the gel is transblotted to nitrocellulose membrane and incubated 
with A) polyclonal rabbit anti-human prostatic acid phosphatase (PAP) antibody or 
B) polyclonal mouse anti human prostate specific antigen (PSA) antibody. The 
results show that a 56 kDa spot is reacted with the PAP antibody and a 32 kDa spot 
is reacted with the PSA antibody. 
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Representative two Dimensional Electrophoresis profiles of 1 h post coital uterine 
fluid flushings from SH, V P X and T X groups. The proteins are first separated on a 
13 cm immobiline drystrip, pi 3-10 and then by a 12 % homogenous SDS-PAGE. 
Finally the protein spots are visualized by silver staining. The spots on the three gels 
are matched and analyzed by PDQuest software under predetermined matching 
criteria. Details are described in Materials and Methods. Data are summarized in 
Fig. 2-9. Spots common for the three gels are indicated by blue circles. Spots only 
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Fig. 2-9 
Venn diagram to show the number of protein spots detect in uterine fluid flushings 
from the three groups. This diagram shows data from 1 h post-coital sample 
separate on pi 3-10 gel. The red, blue and yellow circles represent SH, V P X and T X 
groups respectively. The areas of overlap between the groups indicate the spots that 
are common to the groups. Protein profile analysis results for 1 h post-coital uterine 
fluid flushings on 2-DE gel are shown in the table. The 2-DE gel from V P X and T X 
groups were compared with SH group. The number of matched spots and 






Number of Protein Spots Detected in Uterine Fluid Flushings Collected from 
Females Mated with SH, V P X and T X Males at 1 h after Mating 
Number # of Spots # of Spots # of Spots 
pi range Groups of Spots matched up-regulated down-regulated 
Detected with SH (%) when compare when compare 
with SH with SH 
SH 322 -- -- --
3 to 10 V P X 452 155 (34) 52 103 
T X 402 180(44) 62 118 
81 
Fig. 2-10 
Representative two Dimensional Electrophoresis profiles of 1 h post coital uterine 
fluid flushings from SH, V P X and T X groups. The proteins are first separated on a 
13 cm immobiline drystrip, pi 4-7 and then by a 12 % homogenous SDS-PAGE. 
Finally the protein spots are visualized by silver staining. The spots on the three gels 
are matched and analyzed by PDQuest software under predetermined matching 
criteria. Details are described in Materials and Methods. Data are summarized in 
Fig. 2-11. Spots common for the three gels are indicated by blue circles. Spots only 
find in SH and V P X gels or SH and T X are indicated by red and green circles 
respectively. 
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Fig. 2-11 
Venn diagram to show number of protein spots detect in uterine fluid flushings from 
the three groups. This diagram shows data from 1 h post-coital sample separated on 
pi 4-7 gel. The red, blue and yellow circles represent SH, V P X and T X groups 
respectively. The areas of overlap between the groups indicate the spots that are 
common to the groups. Protein profile analysis results for 1 h post-coital uterine 
fluid flushings on 2-DE gel are shown in the table. The 2-DE gel from V P X and T X 






VPX 命 s TX 
343 213 
Number of Protein Spots Detected in Uterine Fluid Flushings Collected from 
Females Mated With SH, V P X and T X Males at 1 h after Mating 
Number # of Spots # of Spots # of Spots 
pi range Groups of Spots matched ？-regulated down-regulated 
Detected with SH (%) when compare when compare 
V ’ with SH with SH 
SH 242 __ __ __ 
4 to 7 V P X 343 181 (32) 57 114 
T X 213 137(64) 50 87 
85 
Fig. 2-12 
Representative two Dimensional Electrophoresis profiles of 4 h post coital uterine 
fluid flushings from SH, V P X and T X groups. The proteins are first separated on a 
13 cm immobiline drystrip, pi 3-10 and then by a 12 % homogenous SDS-PAGE. 
Finally the protein spots are visualized by silver staining. The spots on the three gels 
are matched and analyzed by PDQuest software under predetermined matching 
criteria. Details are described in Materials and Methods. Data are summarized in 
Fig. 2-13. Spots common for the three gels are indicated by blue circles. Spots only 
find in SH and V P X gels or SH and T X are indicated by red and green circles 
respectively. 
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Venn diagram to show number of protein spots detect in uterine fluid flushings from 
the three groups. This diagram shows data from 4 h post-coital sample which 
separate on pi 3-10 gel. The red, blue and yellow circles represent SH, V P X and T X 
groups respectively. The areas of overlap between the groups indicate the spots that 
are common to the groups. Protein profile analysis results for 4 h post-coital uterine 
fluid flushings on 2-DE gel are shown in the table. The 2-DE gel from V P X and T X 
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M l S . / 
VPX TX 
255 226 
Number of Protein Spots Detected in Uterine Fluid Flushings Collected from 
Females Mated With SH, VPX and TX Males at 4 h after Mating 
Number # of Spots # Spots # of Spots 
pi range Groups of Spots matched up-regulated down-regulated 
Detected with SH (%) when compare when compare 
with SH with SH 
SH 331 -- -- --
3 to 10 VPX 255 139 (54) 58 81 
TX 226 115 (50) 47 68 
89 
Fig. 2-14 
Representative two Dimensional Electrophoresis profiles of 4 h post coital uterine 
fluid flushings from SH, V P X and T X groups. The proteins are first separated on a 
13 cm immobiline drystrip, pi 4-7 and then by a 12 % homogenous SDS-PAGE. 
Finally the protein spots are visualized by silver staining. The spots on the three gels 
are matched and analyzed by PDQuest software under predetermined matching 
criteria. Details are described in Materials and Methods. Data are summarized in 
Fig. 2-15. Spots common for the three gels are indicated by blue circles. Spots only 
found in SH and V P X gels or SH and T X are indicated by red and green circles 
respectively. 
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Venn diagram to show number of protein spots detect in uterine fluid flushings from 
the three groups. This diagram shows data from 4 h post-coital sample which 
separate on pi 4-7 gel. The red, blue and yellow circles represent SH, V P X and T X 
groups respectively. The areas of overlap between the groups indicate the spots that 
are common to the groups. Protein profile analysis results for 4 h post-coital uterine 
fluid flushings on 2-DE gel are shown in the table. The 2-DE gel from V P X and T X 




VPX ^ ^ ^ TX 
Number of Protein Spots Detected in Uterine Fluid Flushings Collected from 
Females Mated With SH, V P X and T X Males at 4 h after Mating 
Number # of Spots # of Spots # of Spots 
pi range Groups of Spots matched u厂egulated down-regulated 
Detected with SH (%) when compare when compare 
with SH with SH 
SH 555 -- -- — 
4-7 V P X 428 167(39) 55 112 



























































































































































































































































































































































































































































































































































































































































One hour post-coital uterine fluid flushings from the three groups separated by 2-D 
electrophoresis as described in Materials and Methods. Fourteen spots that show 
significant differential expressions are highlighted. These spots are identified by 
MALDI-TOF analysis. The intensities of V P X spots are highest among the three 
groups in spots 1-7. The intensities of V P X spots are lowest among the three groups 
in spots 8, 9 and 10. The intensities of spots in all three groups do not differ in spots 
11-14. 
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Ih-spot 8-Prostatic steroid-binding 
protein chain CI precursor 
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Fig. 2-17 
Representative spectra obtain from MALDI-TOF analysis. The protein spots are 
picked from Ihpost coital uterine fluid flushings. Each protein spot is digested by 
Trypsin overnight, mixed with matrix and placed on sample plate for analysis. Each 
peak on the spectrum represents a single digested peptide, and the mass of it is 
shown on the top. The fourteen identified proteins includes: 1) Hyaluronidase 
(HYAL2), 2) Cysteine rich protein 61,3) Angiopoietin 1 (Ang-1), 4) Small inducible 
cytokine subfamily E, 5) Interleukin 12b p40 subunit, 6) Tumor necrosis factor alpha 
induced protein 6 (TSG-6), 7) Androgen binding protein alpha, 8) Prostatic steroid-
binding protein chain CI precursor, 9) C lectin-related protein A, 10) Interleukin 1 
receptor antagonist, 11) Clr-like protein, 12) Prostate spermine-binding protein 
precursor, 13) Lymphotactin and 14) Brain-derived neurotrophic factor (BDNF). 
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1) Hyaluronidase (HYAL2) 
V o y a g e r S p e c # 1 = > A d v B C ( 1 0 0 0 , 0 . 2 , 0 . ” = > M C [ B P = 655 . 9 , 14616 ] 
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2) Cysteine rich protein 61 
V o y a g e r S p e c # 1 = > A d v B C ( 1 0 0 0 ’ 0 . 2 ’ 0 . 1 > = > S M 5 = > M C [ B P = 656.1 , 8 7 6 0 ] 
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3) Angiopoietin 1 (Ang-1) 
V o y a g e r S p e c #1=>AdvBC ( 1000 , 0 . 2 , 0 . 1 )=>SM5=>MC [BP = 1267 .4 , 6 026 ] 
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4) Small inducible cytokine subfamily E 
Voyager Spec #1=>AdvBC(1000’0.2’0.1)=>SIVI5=>MC[BP = 656.1, 14415] 
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5) Interleukin 12b p40 subunit 
Voyage r S p e c #1=>AdvBC(1000,0.2,0.1>=>SM5=>IVIC[BP = 656.1 , 5000] 
… 656.0441 
100-1 」 4999.5 
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6) Tumor necrosis factor alpha induced protein 6 (TSG-6) 
Voyage r S p e c #1=>AdvBC(1000 ,0 .2 ’0 .1 )=>SM5=>MC[BP = 656.0 , 8879] 
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7) Androgen binding protein, alpha 
Voyage r S p e c #1=>AdvBC(1000,0,2，0.1)=>SIVI5=>MC[BP = 1203.5, 12688] 
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8) Prostatic steroid-binding protein chain CI precursor 
Voyager Spe c #1=>AdvBC(1000’0 .2 ,0 .1)=>SM5=>MC[BP = 656.1, 8682] 
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9) C lectin-related protein A 
V o y a g e r S p e c #1=>AdvBC(1000 ,0 .2 ,0 .1>=>SM5=>I\f lC [BP = 1995 .3，8659] 
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10) Interleukin 1 receptor antagonist 
V o y a g e r S p e c #1 二〉AdvBC(1000 ,0 . 2 , 0 . 1>=>SM5=>MC[BP = 656 . 1 , 8 3 39 ] 
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11) Clr-like protein 
V o y a g e r S p e c # 1=>Ad vBC ( 1 0 0 0A2 ’ 0 . 1>=>SM5=>MC [ BP = 656 . 0 , 16206 ] 
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12) Prostate spermine-binding protein precursor (SBP) 
V o y a g e r S p e c #1=>AdvBC (1000 , 0 . 2 , 0 . 1>=>SM5=>MC[BP = 2007 .9，25957] 













10- . ； 10 5737 2011.9285 
842.5283 丨丨• 19|(?.9097 2405.9862 
0 I . II. . i i . • . . I,.., • I A u t J m . ^ • • . . l L . . , 丄 J i l . ^ ！ I , , , 1-0 




V o y a g e r S p e c # 1=>Ad vBC ( 1 0 0 0 , 0 . 2 , 0 . 1 ) =>SM5=>MC [ BP = 655 . 9 , 5 6 46 ] 
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14) Brain-derived neurotrophic factor (BDNF) 
V o y a g e r S p e c #1=>AdvBC (1000 ’0 . 2，0 .1 )=>SM5=>MC[BP = 656 . 0 , 10896 ] 
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RT-PCR analysis of Ih and 4 h post coital uterine tissue samples taken from the 
three groups. RT-PCR are conducted with specific primers for TSG-6. At the mean 
time, the p-actin primers are co-run with the TSG-6 primers as an internal 
calibration. Lane 1 is the D N A ladder, two bands are obtained for six samples which 
are 1128 bp (b-actin) and 692 bp (TSG-6). All the primers for this study are 
designed by Primer 3 online program, and synthesized by Invitrogen Life 
Technologies, Hong Kong. Primers used for RT-PCR is listed in the table. 
Information such as name, sequence, and product size are provided. 
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1 h p.c, uterine tissue 
SH VPX TX 
F ^ n i q llllllip_!i,「,、:ipp^  
1100 bp p-actin 
600 bp TSG-6 
4 h p.c. uterine tissue 
SH VPX TX 
i 
im 





Primer information for TSG-6 and P-actin 
Primer Name Sequence Product Size 
TSG-6 Forward T T T G C T T A T G C G T C T T G C T G 
692 
TSG-6 Backward G A C G G A T G C A T C A C T C A G A A  
P-actin Forward A T G G A T G A C G A T A T C G C T G C G ”。。 
1上 
P-actin Backward C T A G A A G C A T T T G C G G T G G A C 
105 
Fig. 2-19 
The nucleotide sequence analysis of the PGR products. The sequencing result is 
submitted to "Nucleotide Nucleotide BLAST (blastn) sequence analysis services". 
The result shows that the Ih-spots 7 is TSG-6 which is same as the MALDI-TOF 
analysis result. 
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Accession #: NM—0 09398.1 
Mus mus cuius 
Tumor necrosis factor alpha induced protein 6, (TNFAIP6), mRNA 
Length = 1605 
Score = 141 bits (71) 
Expect — 4e-31 
Identities = 121/135 (89%) 
Gaps = 2/135 (1%) 
Strand = Plus / Plus 
Hamster: 4 cggatggggatac-agaatggaatctttc-taactccatatggcttgaacaagcagcagg 61 
I I I I I I I I I I I I I I I I I I I I I m I 丨 II I I I I 丨 I I I I I I I m 丨 I I 丨丨 I I I I II 
Mouse: 111 cggatggggattcaagaacgggatctttcataactccatatggcttgaacaagcagcggg 170 
Hamster: 62 tgtgtaccaccgagaagctcgggctggcaaatacaagctcacctatgcagaagccaagac 121 
I I I I I I I I I I I I I I I I I I I I I I I I I I I III 丨 I I I 丨 I 丨 I I I 丨丨 I 丨 I I I I IN I I 
Mouse: 171 cgtataccacagagaagctcgggctggcagatacaagctcacctacgccgaagccaaggc 230 
Hamster: 122 tgtatgtgaatttga 13 6 
11111 M 111 m I 
Mouse: 231 cgtatgtgaatttga 24 5 
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Fig. 2-20 
The length for TSG-6 PGR product is 128 bp. The sequence is matched with the 
mouse and human sequence, and the result is shown. The hamster sequence shares 
89.8 o/o homology with the human and mouse sequences. 
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TS G6 -Mous e 92 TGCTGTGGGAAGAGGCTCAC GGATGGGGATrCAidiA|C|^G®C!m^MCS 145 
TSGe-human 105 TGCTATGGGMGACACTCMGGATGGG&Arn:A]jG|r&GA^[HTn:ATMC:| 158 
TSG6-haii3ter 1 lAffrpGAacmCATAACl 20 
TSGe-human 159 CCATATGGCTTGMCGjUGCAGCC^GT&blCCACAbAGAAGC^G即CTGG^ 212 
TSG6-hajiister 21 I c C A T A T C ^ G C T T G A A C j i J l l G C A & C 雄 7 4 
TSG6-M0use 200 253 
TSGe-human 213 MTACMGCTCACCTi^GC^GAAC^rAAi^G^G&lGTGT&AAnTG^GGCGqCC 266 
TSCe-haiister 75 M T A C A A G C T C A C C T ^ T G C 妨 1 2 8 
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Fig. 2-21 
Scanning electronmicrographs of the uterine sperm for two difference groups: A) SH 
group and B) VPX group. A female hamster mate with single male from either the 
control or experimental group. At the time of one hour after mating, the female is 
killed and sperm are collected from the uterus. The electronmicrographs are taken at 
6500X magnification. (T: sperm tail, H: sperm head and P: protein strands). 
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Fig. 2-22 
Scanning electronmicrographs of the uterine sperm for two difference groups: A) SH 
group and B) VPX group. A female hamster mate with single male from either the 
control or experimental group. At the time of one hour after mating, the female is 
killed and sperm are collected from the uterus. The pictures are taken at lOOOOX 
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Chapter 3 The Effect of Omission of Male Accessory Sex 




Implantation is a process that involves development of preimplantation 
embryo to the blastocyst stage followed by hatching, apposition and attachment of 
the blastocyst to the endometrial surface epithelium and subsequent invasion of 
the embryo into the endometrial stroma. Successful implantation and fetal 
survival require appropriate communication between the embryo and 
endometrium. The signaling process between embryo and endometrium are done 
largely by cytokines (Kauma, 2002). 
3.1.1. Cytokine & Growth Factor 
The endometrium of most species is recognized as an important site for 
production of cytokines and their receptors. The cellular origin of cytokines varies 
but many predominate in the uterine glandular or luminal epithelium or in the 
decidualized stromal cells (Salamonsen et al., 2000). Over the last decade, 
enormous amount of data have been reported on the production of cytokines, 
growth factor and their corresponding receptors in the endometrium and early 
embryo (Kauma, 2002). 
3.1.1.1. Vascular Endothelial Growth Factor (VEGF) 
Vascular endothelial growth factor (VEGF) is a multifunctional cytokine 
that interacts with two high affinity tyrosine kinase receptors that are selectively 
expressed on vascular endothelium. It is the main factor responsible for increased 
endometrial vascular permeability at implantation. It may regulate endometrial 
endothelial cell proliferation before implantation and at intersites, thus indicating 
that factors or mechanisms other than VEGF may regulate endothelial cell 
proliferation at the site of implantation (Dvorak 2000; Rabbani & Rogers, 2001). 
Pervious study showed that removal of ventral prostate glands alone or all 
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accessory sex glands was associated with reduction of V E G F transcripts and 
protein levels in both the embryo and endometrium at 5-7 days post-coitum. This 
suggested that abnormal embryos sired by males without the ventral prostate 
gland or all accessory sex glands reduced the potential of the uterus to support 
pregnancy (Chow et al., 2003). 
3.1.1.2. Leukemia Inhibitory Factor (LIF) 
Leukemia inhibitory factor (LIF) is a pleiotropic glycoprotein with a 
molecular mass of 32-67 kDa (Kurzrock et al, 1991). LIF is highly expressed by 
epithelial cells in endometrium (Bhatt et al., 1991). Several evidences indicate 
that LIF has an important role in early embryo development and implantation in 
mice (Bhatt et al, 1991) and human (Kojima et al., 1994; Arid et al., 1995). 
Stewart suggested that homozygotic knockout mice deficient in LIF can conceive, 
but the resulting embryos do not implant (1992). In human, LIF m R N A 
expression and protein level were increased in endometrium at the time of 
implantation (Kojima et al., 1994; Arid et al,, 1995). LIF can augment embryo 
implantation by several mechanisms. It enhances blastocyst development in mice 
(Mitchell et al., 1994; Kauma and Matt, 1995), the quality and quantity of 
blastocyst formation of human IVF embryos (Dunglison et al., 1996), blastocyst 
hatching in vitro in sheep and increase in pregnancy rates of embryos cultured in 
vitro and transferred back into recipient ewes (Fry et al., 1992). 
3.1.1.3. Insulin-like Growth Factors (IGFs) 
The insulin-like growth factors (IGFs) include IGF-I A N D IGF-II, both of 
which can mediate a potent mitogenic signal to a variety of cells by binding to the 
IGF-I receptor (IGF-IR) (Pimentel, 1994). In the endometrium, IGF-I is produced 
predominantly during the proliferative phase and its production is oestrogen 
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dependent (Giudice et al., 1998). IGF-II is produced during the secretory phase 
and its production is progesterone dependent. IGFs may have roles in early 
preimplantation embryo development, trophoblast invasion and trophoblast 
growth (Giudice et al, 1998). Recent study shows that decidualized endometrial 
stromal cells are thought to contribute to establishing successful pregnancy by 
expressing a number of gene products. One of the major products from decidual 
cells is insulin-like growth factor binding protein-1 (IGFBP-1). The IGFBP-1 
serves as a modulator of insulin-like growth factor (IGF) protein action in the 
interactions between the decidua and invading trophoblast (Fazleabas et al., 2004) 
3.1.1.4. Interleukin 1 (IL-1) 
Interleukin-1 (IL-1) is an immunoregulatory cytokine with several 
functions, including stimulation of T lymphocyte cytokine production, 
lymphocyte proliferation, macrophage activation and initiation of the 
inflammatory cytokine cascade (Dinarello, 1991). Several evidences support a 
role for IL-1 in implantation. IL-ip expression is upregulated in human 
endometrium during the mid-luteal phase of the menstrual cycle and its expression 
increases further during pregnancy (Kauma et al., 1990). RT-PCR has been used 
to demonstrate that IL-1 p m R N A expression starts at the four-cell stage and 
continues through the blastocyst stage of development in preimplantation mouse 
embryo; however the IL-1 a and IL-IR expressions were not shown on 
preimplantation stage embryo. The same study shows that IL-lp, IL-1 a and 
IL-IRI m R N A s were expressed in preimplantation stage uterus (Takacs and 
Kauma, 1996). These results indicate that signal from the embryo to the materanal 
endometrium can occur during preimplantation phase as the embryo expresses 
IL-lp and the maternal deciduas expresses the IL-IR. There is also an autocrine 
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signaling mechanism, as the deciduas produces IL-la and IL-lp that can act on its 
ownlL-lR. 
IL-1 also stimulates production of LIF (Arid et al., 1995); increases 
endometrial epithelial p-3 antigen expression which is thought to be beneficial for 
blastocyst attachment and augments hCG production by freshly isolated 
trophoblast in vitro (Masuhiro and Matsuzaki, 1991). 
3.1.1.5. Adhesion Molecule 
Adhesion molecules may be important for interaction of the embryo with 
the maternal cellular environment as well as for continuing development and 
survival of the early embryo (Lu et al., 2002). Trophinin have been identified as 
molecules potentially involved in human embryo implantation. Both trophoblasts 
and endometrial epithelial cells express trophinin, which mediates apical cell 
adhesion through homophilic trophinin-trophinin binding (Nakayama et al., 
2003). In a recent study, activated leukocyte cell adhesion molecule (ALCAM) 
has been examined in human blastocysts and endometrium. The result shows that 
the protein expression is found in endometrial luminal and glandular epithelial 
cells. However, RT-PCR analysis demonstrates A L C A M m R N A expression in 
human blastocysts but not 8-cell embryo and morula. The study suggests that 
A L C A M - A L C A M cell adhesion system between embryo and endometrial 
epithelial cells is involved in an initial interaction (Fujiwara et al., 2003). 
3.1.2. Uterine Secretory Proteins 
Uterine secretory proteins play a very important role in embryo 
implantation; some of them are still unexplored. The importance of studying 
uterine secretions is clear in the light of evidence that blastocyst development is 
influenced by the uterine milieu. More recent molecular studies also suggest that 
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after implantation, the matemo-fetal relationship depends on paracrine 
interactions with the surrounding decidua and that decidual products are 
transferred into the fetal compartment. It has also been shown that in rodents, 
uterine epithelial cells are active in endocytosis of macromolecules at both their 
apical and basal surfaces and that endocytosis is under progestational control 
Serum proteins are the predominant macromolecules in the uterine luminal 
fluid of some species but certain proteins not detectable in serum also occur in a 
number of species. The amounts of some of these uterine proteins vary with the 
oestrous cycle or stage of pregnancy and their concentrations are often increased 
during certain critical phases of embryonic development (Waldron-Edward et al, 
1976). Several proteins have been identified in vitro and they appear to be 
secretory products of the endometrium, and are regulated by the major ovarian 
steroid hormones. (Mac Laughlin, 1986). 
3.1.2.1. Estrogen Dependent Protein 
Estrogen stimulates the synthesis and secretion of 115 and 65 kDa proteins 
from rat uterus. Both proteins appear to be subunits of a larger protein with a 
molecular weight of 180 kDa, and this protein appears to be specific to the uterus 
and is produced by epithelial cells. In the rat estrous cycle, peak production 
occurs at estms, and in the immature female, synthesis of the protein is stimulated 
by estrogen and inhibited by progesterone. An estrogen-dependent protein was 
purified form uterine flushings of estrogen-treated cats, and was localized to 
endometrial epithelial cells of cats by immunocytochemistry. Epithelial cells 
from animals treated with estradiol for 4, 7，or 14 days and estrogen- primed 
animals treated with progesterone for 2 days showed positive immunostaining. 
Staining was absent in untreated ovariectomized animals and in estrogen-primed 
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animals treated with progesterone for 4 days. Immunostaining was commonly 
observed in the lumen of deep glands, but absent in the cells of the surface 
epithelium, stroma, and myometrium. Immunoreactivity is not found in other 
organs such as the oviduct, kidney, liver, pancreas and lung. Therefore, Murray 
and Verhage (1985) claim that this specific uterine secretory protein is estrogen-
dependent and uterine-specific. 
3.1.2.2. Progestin-Dependent Endometrial Protein 
A hormone-dependent endometrial protein designated progesterone-
dependent endometrial protein (PEP) has been isolated and characterized from 
human uterus. PEP is a glycoprotein that is synthesized in endometrial glands and 
secreted into the blood. Its synthesis increases more than 1000-fold during 
pregnancy (Dichek et al, 1991). Menstrual cycles that are anovulatory or with a 
corpus luteum defect are associated with low luteal-phase serum PEP levels. In 
both pre- and postmenopausal women, serum PEP levels increase following a 
progestin challenge, demonstrating that PEP is indeed a progestin-dependent 
protein. 
The progesterone-dependent secretory protein is also synthesized by cat 
and ewe endometrium (Li et al., 1992). Boomsma and Verhage (1987) studied 
uterine flushing and culture media from endometrial explants with one-
dimensional and two-dimensional gel electrophoresis to identify proteins. A Mr 
30,000 protein with isoelectric points between 6.5-7.0 was detected in samples 
collected from 7- to 11-day pregnant cats but absent in sample from estrous and 3-
to 5-day pregnant cats. In ovariectomized, steroid-treated animals, the Mr 30,000 
protein was only detected in uterine flushings and media from those animals 
treated with progesterone, regardless of the presence or absence of estradiol-
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priming and/or simultaneous estradiol treatment. This study shows that this 
specific protein is progesterone-dependent, and first appears within uterine lumen 
soon after the arrival of the blastocyst and continues to be present during 
implantation. 
A protein of Mr 14,000 has been identified in the medium after culturing 
ewe conceptuses in vitro, and uterine flushing of non-pregnant ewe during the 
luteal phase of the estrous cycle. Western blotting procedures with a anti-14K 
antiserum showed that endometrium from ovariectomized ewes began to release 
the 14K protein after 6 to 14 days of progesterone treatment. Immunostaining of 
tissue from day 16 pregnant ewes and from ewes treated with progesterone for 14 
or 30 days shows that the protein was confined to the surface and upper glandular 
epithelium of the endometrium and absent from the deep glands (Kazemi, 1990). 
3.1.2.3. Uteroglobin 
Uteroglobin (UG) is a progesterone binding protein, and is a major 
constituent of uterine fluid before implantation in the rabbit. However, 
Uteroglobin is also found in other organ, particularly in epithelial cells, including 
those of respiratory, gastrointestinal, and genito-urinary systems of both genders 
(Miiller-Schottle, 1999). It has also been detected in rabbit extraembryonic matrix 
before implantation (Herrler et al., 2002) and in the rabbit day 4 to day 6 p.c. 
blastocyst (Hegele-Hartung et al,, 1991). Synthesis of uteroglobin in 
endometrium is induced by progesterone and progestins, both of which increase 
the level of specific m R N A and influence posttranscriptional events so that 
uteroglobin production increases by threefold more than the level of its m R N A . 
The protein is detected in uterine flushings between days 3 and 8 of pregnancy. 
Immunohistochemical techniques localized it to nonciliated epithelial cells. 
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uteroglobin is also produced in other tissue such as prostate and seminal vesicle; 
the hormonal dependence of expression is quite different (Manyak et al., 1988). 
In addition to binding to progesterone, uteroglobin has been shown to inhibit 
trypsin and to block antigenicity of blastocysts and sperm in vitro (Manjunath et 
al., 1984). 
Compared with rabbit uteroglobin, human uteroglobin displays some 
significant similarities and a number of interesting differences in its expression 
pattern. In early pregnant rabbits, uteroglobin is the major protein in endometrial 
secretions and is found in milligram amounts in one individual uterus. In contrast, 
human uteroglobin expression is considerably lower, and detection of uteroglobin 
m R N A requires highly sensitive methods. Uteroglobin is a secretory protein 
located apically in both glandular epithelial cells and in the luminal epithelium. In 
the follicular stages of endometrium, uteroglobin expression was either not 
detected or was only poorly detected, whereas, in the luteal phase, uteroglobin 
expression could be detected up to the end of the menstrual cycle (Miiller-Shottle, 
1999). 
3.1.2.4. Uteroferrin 
Uteroferrin is a lavender-colored iron-containing basic glycoprotein 
secreted by pig endometrium. Like uteroglobin, it is induced by progesterone, the 
rate of secretion rises to 2g per day in mid-pregnancy. It accounts for 15% of the 
total protein secreted by the endometrium 15 days after estrus. Since it is detected 
in allantoic fluid between days 30 and 60 of pregnancy, the function of uteroferrin 
may be connected with the transfer of iron across the chorioallantois (Saunders et 
al” 1985). Uteroferrin is synthesized and secreted by nonciliated cells of the 
glandular epithelium. It immunolocalizes to small vesicles and tubules as well as 
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larger vacuoles. This evidence points to a pathway of transfer of the glycoprotein 
from endometrial secretions to fetal blood and, presumably as a source of iron, to 
fetal liver (Raub et al, 1985). 
3.1.2.5. Prolactin 
Prolactin has been identified as a secretory protein of human endometrium 
and decidua. Prolactin is characteristic of late secretory endometrium; not 
detected prior to day 22 of the normal cycle (Riddick and Maslar, 1979). 
Immunohistochemical studies have demonstrated prolactin in the cytoplasm of 
decidualized stromal cells of late-secretory phase endometrium, although it has 
also been detected within glandular epithelial cells. (McRae et al, 1986) 
Prolactin is found in amniotic fluid, where its concentration is up to 100-fold 
greater than in maternal blood. The concentration in amniotic fluid rises to a 
maximum at 18 weeks of gestation and falls in later pregnancy. The detection of 
prolactin in fetal membranes is consistent with its originating in decidua before 
crossing the chorioamnion. Its function is presumably that of paracrine hormone, 
acting either at the chorioamnion or the fetus. It may play a role in the control of 
electrolyte exchange across the amniochorion, influences synthesis of 
prostaglandins, and modulates surfactant production by type II pneumocytes of 
fetal lung (Healy and Hodgen, 1983). 
3.1.2.6. Glycodelin 
Glycodelin is a major glycoprotein that is synthesized in the endometrium 
in response to progesterone and relaxin. It was localized to secretory endometrial 
glands and to the glandular epithelium of the decidua spongiosa. Glycodelin is 
absent from the endometrium during the fertile proliferative phase, but is 
synthesized in this tissue during the secretory phase of the ovulatory cycle and is 
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abundant during the last week of the luteal phase (Damario et al, 2001). 
Preliminary data indicate that glycodelin has immunosuppressive effects that are 
postulated to facilitate the embryonic evasion of the maternal immune response 
(Vigne et al, 2001). 
Aim of Study 
The uterine fluid component may vary due to the presence of embryo. At 
60 \v p.c., the morula is still in the oviduct, the uterine fluid may not contain 
secretory component induced by embryo. At 72 h post coitum, the blastocyst 
enters the uterus and started to communicate with the uterus. At that time, the 
uterine fluid is constituted by both the endometrium and embryo (see Fig. 3-1). 
W e analysed uterine fluid flushing at two different time points: 60 hp.c. (morula 
in oviduct) and 72 hp.c. (blastocyst in uterus) to study the difference. Previous 
study shows that the absence of A S G reduces implantation rate, therefore, we also 
studied how the profiles of uterine fluid protein was affected in the three 
experimental groups at the same time points. 
The aim of this chapter is to: 
1. demonstrate that uterine protein components is altered by an implanting 
embryo 
2. demonstrate that absence of A S G components at mating alters the 
periimplantation uterine protein profiles 
3. use two dimensional electrophoresis and MALDI-TOFF to identify 
proteins that are significantly change 
4. use western blotting and polymerase chain reaction to verify transcription 
or translation of identified proteins 
3.3. Method and Materials 
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All solutions and buffers were listed on appendix A. General chemicals 
used were of the highest grades and were purchased from Sigma, St. Louis, M O , 
U.S.A. unless otherwise specified. 
3.3.1. Animal and Surgery 
The female and male hamster groups used were the same as described in 
section 2.2.1.. 
3.3.2. Collection of Biological Samples 
Biological samples were collected for experiment such as 2-D 
electrophoresis, PGR and western blotting. 
3.3.2.1. Uterine Fluid 
Samples were collected at 60 and 72 h post coitum from the three groups 
(SH, VPX, and TX). The procedure for uterine fluid sample collecting was same 
as described in section 2.2.2.1.. 
3.3.2.2. Uterine Tissue 
Uterus tissues samples were collected at 60 and 72 h post coitum from the 
three experimental groups (SH, VPX, and TX). The uteri were removed as 
described in the section 2.2.2.1" Then, the uterine contents were flushed out with 
0.85% saline and the tissue was stored at -70。C until R N A extraction. 
3.3.3. Quantification of Protein 
A Bradford dye-binding protein assay was performed for quantifying 
protein concentration for each sample. The detail procedure was described in 
section 2.2.5.. 
3.3.4. Two Dimensional Electrophoresis 
Soluble proteins extracted from female hamster uterine fluid flushing were 
analyzed by two dimensional gel electrophoresis as described in section 2.2.6.. 
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3.3.5. Identification of Proteins 
The protein spots were scanned, digested and analyzed by MALDI-TOF as 
described in section 2.2.7.. 
3.3.6. Confirmation of Growth Differentiation Factor-8 (DGF-8) by PGR 
Growth differentiation factor-8 (GDF-8) found in 72 h p.c. uterine fluid 
flushing was confirmed by RT-PCR (appendix K). R N A was extracted from 72 h 
uterus tissue according to protocol described in appendix I. Primers were 
designed by using the online database-Primer 3 based on the conserved regions 
found in mouse and human sequences and synthesized by Invitrogen 
Biotechnology, Hong Kong. Primer pairs were: sense: 5'-GTG G A T G G A A A A 
C C C A A A TG-3', antisense: 5,-TGG TCC T G G G A A G G T T A G AG-3'. p-actin 
sense: 5,-ATG G A T G A C G A T A T C G C T GCG-3,, antisense: 5,-CTA G A A 
G C A TTT G C G G T G GAC-3, primers were co-amplified as internal control. 
lOfil PGR product was mixed with Ijiil 6X loading dye and run on 2 % agarose in 
0.5X TBE buffer at constant 70V for one hour. The agrose gel was then stained 
with 0.1% ethidium bromide (EB) staining buffer. The amplicons were visualized 
with a U V transilluminator (FluorChem T H 8000, Alpha Innotech Corporation, 
San leandro, CA). The sequence of PGR product with the predicted size was 
analyzed by DragonTech Ltd, Hong Kong, a commercial D N A sequencing 
service. Finally, the sequence was matched with the mouse and human sequence 
by Blast for homology. 
3.3.7. Confirmation of GDF-8 by Western Blotting 
GDF-8 was confirmed by western blotting (Appendix J) on 72 h p.c. 
uterine fluid flushing collected according to section 3.3.2.1.. First of all, the 
proteins were separated by 2-D electrophoresis as described in section 3.3.4.. The 
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primary antibody used was mouse anti-goat growth differentiation factor-8 (GDF-
8) (Santa Cruz Biotechnology, Inc, Santa Cruz, CA) diluted 1 to 1000. Finally, 
GDF-8 immunoreactivity was detected by using chemiluminescence E C L ™ 
Advance Western Blotting Detection Kit (Amersham Bioscience, Sweden). 
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3.4. Results 
3.4.1. Protein Concentration 
Protein concentrations of uterine fluids from different groups collected at 
60 and 72 h p.c. were measured. Table 3-1 summarizes the results. 
Concentrations in 60h p.c. uterine fluid flushing were 3.71 士0.238, 3.27±0.225, 
and 3.92士0.179 mg/ml for SH, V P X and T X groups respectively. Concentrations 
in 72h px. uterine fluid flushing were 6.18±0.224, 7.47士0.360 and 6.19土0.293 
mg/ml for SH, V P X and T X groups respectively. The protein concentration for 
72 hp.c. uterine fluid flushing was higher then 60 hp.c. sample for all the three 
groups. Data was analyzed by A N O V A followed by unpaired two-tail Student-
test;户<0.05 intra-group comparison at both time point for SH, V P X and T X 
groups. 
3.4.2. 60 Hours Post Coitum 
3.4.2.1. Protein Profile 
Proteins in 60 h p.c. uterine fluid flushing were separated by 2-D 
electrophoresis. They were focused in two pi ranges for the first dimension (lEF). 
Results from using pH 3-10 two dimensional gels for SH, V P X and T X are shown 
in Fig. 3-2 and Fig. 3-3. There were 489, 440 and 458 spots in SH, VPX, and T X 
respectively. Among those spots, 179 were common to all groups; 271 spots were 
detected in SH and V P X only; 210 spots were detected in V P X and T X only; and 
225 spots were detected in SH and T X only. Results for the pH 4-7 two 
dimensional gels are shown in Fig. 3-4 and Fig. 3-5. In this set of analyses, 501, 
472 and 431 spots were detected in SH, VPX, and T X respectively. Among those 
spots, 139 spots were detected in all groups; 229 spots were detected in SH and 
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V P X only; 198 spots were detected in V P X and T X only; and 355 spots were 
detected in SH and T X only. 
3A2.2. Differentially Expressed Protein Spots and Proteins Identification 
Protein spots with significantly different expression levels in the three 
groups were picked for MALDI-TOF analyses. Nine proteins were identified 
from 60 h post coital uterine fluid flushing. The M O W S E score, percentage of 
peptide matched/peptide total, accession number, observed molecular weights/pl, 
and theoretical molecular weights/pl of each protein were listed in Table 3-2. The 
spot intensity bar charts and the spots from the three groups are shown in Fig. 3-6. 
Nine protein spots were successfully identified by MALDI-TOF analyses. The 
representative spectra of identified protein spots were shown on Fig. 3-7. Those 
proteins includes 1) Plasminogen activator inhibitor (PAI), 2) Colonic mucin 
M U C 2 , 3) Alpha-1-ingibitor III, 4) Angiopoietin 2, 5) Placental prolactin-like 
protein B, 6) Viperin 7) Contrapsin C-term, 8) Trypsin-like protease p98, and 9) 
Protein FAM20B precursor. 
3.4.3. 72 Hours Post Coitum 
3.4.3.1. Protein Profile 
Protein in 72 h p.c. uterine fluid flushing were separated by 2-D 
electrophoresis. They were focused in two pi ranges in the first dimension (lEF). 
Results from using pH 3-10 two dimensional gels for SH, V P X and T X are shown 
in Fig. 3-8 and Fig. 3-9. There were 362, 268 and 310 spots in SH, VPX, and TX 
respectively. Among those spots, 133 spots were detected in all groups; 184 spots 
were detected in SH and V P X only; 166 spots were detected in V P X and T X only; 
and 192 spots were detected in SH and T X only. Results for the pH 4-7 two 
dimensional gels are shown in Fig. 3-10 and Fig. 3-11. In this set of analyses, 
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592, 326 and 538 spots were detected in SH, VPX, and T X respectively. Among 
those spots, 261 spots were detected in all groups; 284 spots were detected in SH 
and V P X only; 274 spots were detected in V P X and T X only; and 488 spots were 
detected in SH and T X only. 
3.4.3.2. Differentially Expressed Protein Spots and Proteins Identification 
Protein spots with significant differences were picked for MALDI-TOF 
analyses. Nine proteins were identified from 72 h post coital uterine fluid 
flushing. The M O W S E score, percentage of peptide matched/peptide total, 
accession number, observed molecular weights/pl, and theoretical molecular 
weights/pl of each protein were listed in Table 3-3. Nine protein spots were 
successfully identified by MALDI-TOF analyses. The spot intensity bar charts 
and the magnified spots from the three groups were shown on Fig. 3-12. 
The representative spectra of identified spots were shown in Fig. 3-13. 
Those proteins included: 1) Prolactin-like protein F, 2) Alpha-2u globulin PGCL5, 
3) Trypsin-like protease p98, 4) Osteoclast differentiation factor, 5) Prolactin-like 
protein I, 6) Growth differentiation factor 8 (GDF-8), 7) Beta actin (p-actin), 8) 
Interleukin 12b p40 subunit, 9)Tumor necrosis factor alpha induced protein 6 
(TSG-6). 
3.4.3.3. Confirmation of Growth differentiation factor 8 (GDF-8) 
At 72 h after mating, the combination of laser densitometry and MALDI-
TOF analyses indicated that GDF-8 was up-regulated in uterine fluid collected 
from V P X group compared with the SH control. The presence of GDF-8 in 72 
P.c. uterine tissues was confirmed by RT-PCR (Fig.3-14). The PGR product sizes 
for all three samples were around 300bp; and the predicted PGR product size for 
the specific primer pairs were 324bp. For co-run p-actin primer pairs, the PGR 
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product sizes for all six samples were around llOObp; and the predicted PCR 
product size for the specific primer pairs were 1128bp. Fig. 3-15 showed the 
search result of the partial nucleotide sequence of the PCR product. The search 
result showed that growth differentiation factor 8 of the mouse {Mus musculus) 
was 94% homologous to our submitted PCR product sequence. On Fig 3-16, the 
hamster GDF-8 sequences was compared with human and mouse sequences; the 
matched nucleotides were highlighted. 
The western blot result showed immunoreaction with mouse anti-goat 
GDF-8 (Fig. 3-17), the sample had an estimated pi of 6.2 and a molecular weight 
of 45 kDa. 
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3.5. Discussion 
Protein composition of uterine flushings has been known to change at 
different stages of pregnancy (Wang and Brooks, 1986). In this chapter, we use 
proteomic techniques such as 2-D electrophoresis and MALDI-TOF to identify 
proteins in periimplantation uterine fluid flushing. Finally, we confirm the uterine 
origin of one of the identified proteins by RT-PCR and western blotting. W e 
prove that the protein composition is different in the presence of embryos. The 
omission of some or all components of A S G secretion from the ejaculate does 
have an effect on uterine fluid protein profile at the time of implantation. 
The results presented in this study demonstrate that periimplantation 
uterine fluid protein changes with time (the presence of implanting embryos); and 
the changes are in terms of quality and quantity. In all three groups, uterine fluid 
protein concentrations increased from 60 to 72hp.c.. Implantation is a complex 
process. When the embryo prepares for implantation, a lot of cytokine, growth 
factor and adhesion molecules are secreted by both embryo and maternal 
endometrium (Lei et al., 2004). The increased amount of protein is secreted by 
the endometrium upon stimulation by the embryo and the secretion by the embryo 
itself. Interestingly, all three groups have fewer protein spots at 72h p.c. as 
compared to 60h p.c. regardless of whether the first dimension is focused at pi 3-
10 range. This result tells us that more proteins are secreted into the 72h p.c. 
uterine lumen; however, fewer varieties of proteins are secreted. In all groups, 
more protein spots can be detected by lEF separating at a narrow as compared to a 
broad range pi. 
For V P X group, the protein concentration increases by 229 % from 60 h to 
72 hp.c.. The increase is largest among the three groups but the change in the 
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number of protein spots is least for both lEF focusing range. Also, the protein 
profiles of SH and T X groups have the best match. In particular, at 60 h post 
CO如I uterine fluid flushing, the matched spots for SH and T X group almost 
double that between SH and V P X group. All these results indicate that removal of 
V P G alone induces more change compared with total absence of ASG. Previous 
studies have also demonstrated that V P X group embryos have the lowest 
implantation rate among three groups. Our study suggests that this may be due to 
the larger deviation of the uterine mileu of V P X group from the control. 
Identification of differentially expressed spots may help to understand the 
mechanism. Nine such proteins were identified from the both 60h and 72h 
samples. They include protease inhibitors, virus inhibitory protein, and secretory 
proteins. The functions of some of these proteins are discussed. However, due to 
the limitation of time imposed by the study period only one was confirmed. 
Plasminogen activator inhibitor (PAI) is an inhibitor for urokinase 
plasminogen activator (uPA). The plasminogen-activating system is suggested to 
participate in degradation of extracellular matrix (ECM) and modulation of cell 
adhesion and migration. Elevated m R N A level of PAI-1 in endometriotic and 
endometrial stroma from women with endometriosis was reported (Bmse et al., 
2004). Ovarian steroids may elevate the concentration of PAI-1. In vivo study 
shows that both estradiol (E2) and progesterone (P4) enhanced PAI-1 production 
in endometrial cells. P4 also enhanced the production in stromal cells. PAI-1 is 
also expressed in trophoblasts where it is not notably influenced by E2 or P4 
(Ueyama et al., 2002). In the present study, PAI-1 expression is decreased in the 
T X group compare to control group in 60 h post coital uterine fluid flushing. This 
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may suggest impairment of cell adhesion migration and modification of 
extracellular materials in preparation for implantation. 
Colonic mucin (MUC2) is a secretory glycoprotein originally reported to 
be secreted by intestinal goblet cells and is a major component of the intestinal 
epithelial mucus. M U C 2 gene expression was primarily restricted to the intestinal 
tract (Ho et al., 1993). The function of M U C 2 is considered to protect intestinal 
epithelial surface, but regulation of M U C 2 mucin production in immune response 
is not completely understood (Iwashita et al, 2003). The present study is the first 
report of M U C 2 protein expression in uterine fluid. Both V P X and T X groups 
express more M U C 2 than the control in 60 h post coital uterine fluid flushing. 
W e suggest that M U C 2 may cover the epithelial surface of the uterus and that 
increased amount of M U C 2 may modulate embryo-epithelial attachment. 
Alpha-1-inhibitor III is a macroglobulin detected in liver, plasma, testes 
and epididymis (Leone et al., 2000). Quantification of alpha-1-inhibitor III in 
serum is used to assess systemic inflammatory response (Raymond et al., 1997). 
It is also a protease inhibitor, which forms a plasma complex with 
immunoregulatory plasma protein alpha 1-microglobulin (alpha 1-m) (Falkenberg 
et al., 1995). The uterine alpha-1-inhibitor III may also come from blood. One 
of the functions of seminal plasma is suppression of inflammation. Our result 
shows that T X group has the highest expression of Alpha-1-inhibitor III among 
the three groups in 60 h post coital uterine fluid flushing which may implies 
higher level of inflammatory response in this group. Interestingly, the Alpha-1-
inhibitor expression for V P X group is even lower that SH group. 
Viperin is an endoplasmic reticulum-associated and interferon-inducible 
virus inhibitory protein. Little is known about this protein (Chin and Cresswell, 
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2001). It is likely that the viperin in uterine fluid comes from degraded 
endometrial epithelial cells. Virus induces INF in infected cells which synthsize 
viperin to contain virus infection, slows vims replication and eliminate vims 
infected cells by apoptosis. Less viperin is found in both V P X and T X groups in 
60 h post coital uterine fluid flushing. This implies that the endometrial epithelial 
cells are less capable of combating viral infection. This finding supports the 
notion that A S G secretions do have an anti-viral function as reported previously 
(Lee et al, 1996). 
Prolactin is secreted by the decidualized endometrium at the time of 
predicted conception and, in the event of pregnancy, local expression and 
secretion of prolactin persists until term (Jabbour and Critchley, 2001). Placental 
prolactin-like protein B (rPLP-B) is identified in our uterine fluid samples. The 
mt Placental prolactin-like protein B (rPLP-B) complementary D N A originally 
cloned from a late term placental library hybridizes to transcripts in the deciduoma 
tissue artificially produced in pseudopregnant rats. The expression of rPLP-B in 
deciduoma is first observed 48 h (pseudopregnancy day 7) after the deciduogenic 
stimulus and increases to a maximum by 96-120 h (pseudopregnancy day 9-10). 
rPLP-B is concomitantly expressed by the decidual cells of maternal origin and 
the cytotrophoblast of fetal origin around day 13 of pregnancy (Croze et al., 
1990). Prolactin-like protein F (PLP-F) is a secreted glycoprotein hormone which 
participates in the control of matemal-fetal adaptations to pregnancy (Muller et 
aL, 1998). In the rat, trophoblast giant cells were found to be the major source of 
PLP-F, with a lesser contribution from spongiotrophoblast cells late in gestation. 
The present study is the first report of PLP-F expression during the 
periimplantation stage of pregnancy. Prolactin-like protein I is also a members of 
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the large rat prolactin gene family located on chromosome 17 that is expressed in 
one or more placental trophoblast cell types and maternal decidua at specific times 
during pregnancy (Ozturk et al., 2003). Our identification of prolactin-like protein 
F and prolactin-like protein I are in 72 hp.c. uterine fluid flushing confirms the 
presence of prolactin at the time of implantation. 
Angiopoietin 2 (Ang 2) is an endothelial cell-related factor for 
development and maintenance of all vessels (Krikun et al, 2004). Angiogenesis 
is a key event in implantation of a blastocyst. Previous study suggests that Ang 2 
is involved in the preparation of endometrium for implantation, remodeling of the 
maternal vasculature and trophoblast invasion during the periimplantation period 
(Rowe et al, 2003). In the present study, its expression in TX is about 5 times 
higher than SH and V P X groups. This overexpression could be interpreted as an 
effort to augment apparently less active vasculogenesis, a situation which is quite 
similar to increased expression of plasma vascular endothelial growth factor 
(VEGF) in chronic congestive heart failure cases (chong et al., 2004). 
Growth differentiation factor-8 (GDF-8) was detected and confirmed in 
72h/?.c. uterine fluid flushing by western blotting (Fig. 3-17). RT-PCR confirms 
its transcription in uterine tissue. No pervious study localizes this gene or its 
protein product in the uterus. GDF-8 is well known as a myostatin that belongs to 
the transforming growth factor (TGF)-beta superfamily. Its major function is 
inhibition of proliferation and differentiation of skeletal muscle (McPherron et al, 
1997). Recently study also suggests that it plays a major role during myogenesis, 
RT-PCR result shows that it is can be found in embryos, from one-cell stage 
onward (Amali et al., 2004). To the best of our knowledge GDF-8 has never been 
found in the reproductive system. Our demonstration of its transcripts in the 
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uterus shows that it may regulate smooth muscle proliferation and growth of the 
implantation and post-implantation uterus. 2-D electrophoresis indicates that the 
protein expressions for the three groups are the same. However, the PGR result 
shows the m R N A level is higher in the V P X group. This finding may tell us that 
all the m R N A are translated into protein, or maybe not all the protein are released 
into the uterine fluid. 
Beta actin ((3-actin) is a cytoplasmic protein. It was identified in two-
dimensional polyacrylamide gel electrophoretic analysis of ovine periimplantation 
uterine luminal fluid proteins in the pervious study (Lee et al, 1998). p-actin 
comes from degraded cells and may indicate the level of epithelial degradation or 
embryonic degeneration during implantation. The expression for p-actin for the 
three groups is the same. 
Tumor necrosis factor alpha induced protein 6 (TSG-6) encodes a 34 kDa 
secretory glycoprotein that can be detected in 1 h and 72 h p.c. uterine fluid 
flushing. W e suspect that it co-expresses with TNF-a. The expression of TSG-6 
may be directly influenced by TNF-a stimulation. It is found in a variety of cells 
including leukocytes, fibroblasts, and chondrocytes. A large amount of TSG-6 is 
detected in synovial fluids of patients with rheumatoid arthritis and smaller 
amounts in patients with osteoarthritis (Wisniewski et al., 1993). TSG-6 
irreversibly interacts with Inter-alpha-inhibitor (lal), a serine protease inhibitor 
and constituent of normal plasma, resulting in the formation of a stable 120 kDa 
complex (Wisniewski et al, 1994). TSG-6 protein has a powerful anti-
inflammatory effect on acute inflammation (Wisniewski et al., 1996) and against 
chronic inflammation (Mindrescu et al‘, 2000). TSG-6 is expressed by the three 
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1. The presence of implanting embryo induces quantitative and qualitative changes 
in soluble proteins of the uterine lumen. 
2. Ablation of accessory sex glands change the uterine protein compositions during 
periimplantation in SH, VPX and TX groups. 
3. Most of the proteins identified in periimplantation uterine fluid are protease 
inhibitor and inflammatory proteins. 
4. Protein expression of GDF-8 remains similar for the three groups in 72 h post 
coital uterine fluid flushing. However, the m R N A expression for VPX group is 
dramatically increased. 
5. TSG-6 appears in post coital and periimplantation uterine fluid flushing. The 
protein expressions for the three groups remain the same. 
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Legends and Figures 
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Fig. 3-1 
Illustration of embryo journey during early stages of pregnancy. Once the sperm 
fertilizes the oocyte, the embryo started to move to the uterus for implantation. At 
60 h post coitum, the morula still in the oviduct. At 72 h post coitum, the blastocyst 
enters the uterus and prepare for implantation. 
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Protein content of uterine fluid flushing. Sample were collected by 
flushing the two uterine horns with 1 ml 0.85 % saline containing 
protease inhibitor at 60 or 72 h after the female was mated with males 
from SH, V P X and T X male groups. 
Protein Concentration 
h after 
Group mating N Mean (mg/ml) Range (mg/ml) 
~ ^ 8 3 . 7 1 ± 0 . 2 4 3 . 3 8 - 4 . 0 6 
7 2 1 1 6 . 1 8 ± 0 . 2 2 5 . 8 3 - 6 . 4 2 
^ ^ 8 3 . 2 7 ± 0 . 2 3 2 . 0 0 - 3 . 5 4 
7 2 1 1 7 . 4 7 ± 0 . 3 6 6 . 8 6 - 8 . 0 2 
~ ^ 8 3 . 9 2 ± 0 . 1 8 3 . 6 3 - 4 . 1 5 
7 2 1 1 6 . 1 9 士 0 . 2 9 5 . 8 0 - 6 . 6 7 
N: Number of Animals 
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Fig. 3-2 
Representative two Dimensional Electrophoresis profiles of 60 h post coital uterine 
fluid flushings from SH, V P X and T X groups. The proteins are first separated on a 
13 cm immobiline drystrip, pi 3-10 and then by a 12 % homogenous SDS-PAGE. 
Finally the protein spots are visualized by silver staining. The spots on three gels are 
matched and analyzed by PDQuest software under predetermined matching criteria. 
Details are described in Materials and Methods. Data are summarized in Fig 3-3. 
Two dimensional markers are indicated by the black circles. Spots appear in all 
three gels are indicated by blue circles. Spots only found in SH and V P X gels or SH 
and T X are indicated by red and green circles respectively. 
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Fig. 3-3 
Venn diagram to show number of protein spots detect in uterine fluid flushings from 
the three groups. This diagram shows data from 60 h post-coital sample which 
separated on pi 3-10 gel. The red, blue and yellow circles represent SH, V P X and 
T X groups respectively. The areas of overlap between the groups indicate the spots 
that are common to the groups. Protein profile for 60 h post-coital uterine fluid 
flushings on 2-DE gel are shown in the table. The 2-DE gels from V P X and T X 







Number of Protein Spots Detected in Uterine Fluid Flushings Collected from 
Females Mated with SH, V P X and T X Males at 60 h after Mating 
1 n nc^  . # of Spots # of Spots 
Number # of Spots , ^  . , , ^  . 丁 广 ^ , , up-regulated down-regulated 
pi range Groups of Spots matched 
, .1。TT/n/、when compare when compare 
Detected with SH (o/o)〜池 sS with SH 
SH 489 - -- --
3 to 10 V P X 440 271 (62) 121 150 
T X 458 225 (49) 97 138 
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Fig. 3-4 
Representative two Dimensional Electrophoresis profiles of 60 h post coital uterine 
fluid flushings from SH, V P X and T X groups. The proteins were first separated on a 
13 cm immobiline drystrip, pi 4-7 and then by a 12% homogenous SDS-PAGE. 
Finally the protein spots were visualized by silver staining. The spots on three gels 
were matched and analyzed by PDQuest software under predetermined matching 
criteria. Details are described in Materials and Methods. Data are summarized in 
Fig 3-5. Spots appear in all three gels are indicated by blue circles. Spots only 
found in SH and V P X gels or SH and T X are indicated by red and green circles 
respectively. 
148 
4 5 6 7 
M W pi I I  
(kDa) 
oij T-
116.0 J i 
66.2 |i .二’ ^ m k ^ 
I • • 〜 誦 寺 
35.0 • r f 
25.0 # •、 • • ^ • ^ ' 议 J f 
18.4 I :••，：！ 
14.4 _ ⑩ • 
116.0 m V P X ！ flpE 
66.2 _ — ' • ‘ L 
4 5 。 • • 
35。I • 1 : ^  
25.0 1 • 卞 • • f 
18.4 僅‘ ® • 
14.4 I ^ f ^ 
1 1 6 .。• ^ ^ 一 〒 ^ ^ ^ ^ ! ^ 
45.0 卜 〜 — f | 1 
35.0 屬 ’ ：.•. . v ^ r i H 
25,0 ^ . • 〜 . • “ 《 . f 
18.4 M I 




Venn diagram to show number of protein spots detect in uterine fluid flushings from 
the three groups. This diagram shows data from 60 h post-coital sample which 
separated on pi 4-7 gel. The red, blue and yellow circles represent SH, V P X and T X 
groups respectively. The areas of overlap between the groups indicate the spots that 
are common to the groups. Protein profile for 60 h post-coital uterine fluid flushings 
on 2-DE gel are shown in the table. The 2-DE gels from V P X and T X groups are 




. 公 . 
VPX TX 
472 431 
Number of Protein Spots Detected in Uterine Fluid Flushings Collected from 
Females Mated With SH, VPX and TX Males at 60 h after Mating 
n ^^ . # of Spots # of Spots 
Number of P up-regulated down-regulated 
pi range Groups Spots Detected = 二 w h e n compare when compare 
withSH(%) withSH withSH 
SH 501 - - -
4 to 7 VPX 472 229 (49) 68 161 






































































































































































































































































































































































































































































































































































































60 h post-coital uterine fluid flushings from the three groups were separated by 2-D 
electrophoresis as described in Materials and Methods. Nine spots that show 
significant differential expression are highlighted. These spots are identified by 
MALDI-TOF analysis. The intensities of V P X spots are highest among the three 
groups for spots 1 and 2. The intensities of T X spots are highest among the three 
groups for spots 3, 4 and 5. The intensities of spots in all three groups are close in 
spots 6, 7, 8 and 9. 
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60 h spot 3—AIpha-1-inhibitor III 
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60 h spot 5—Placental prolactin-like protein B 
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Representative spectra obtain from MALDI-TOF analysis. The protein spots are 
picked from 60 h post coital uterine fluid flushing 2-D gels. Protein spots are 
digested by trypsin overnight, mixed with matrix and placed on sample plate for 
analysis. Each peak on the spectrum represents a single digested peptide, and the 
mass of it is shown on the top. The nine identified proteins includes: 1) Plasminogen 
activator inhibitor (PAI), 2) Colonic mucin (MUC2), 3) Alpha-1-inhibitor III, 4) 
Angiopoietin 2 (Ang-2), 5) Placental prolactin-like protein B (PLP-B), 6) Viperin, 7) 
Contrapsin C-term, 8) Trypsin-like protease p98, and 9) Protein FAM20B precursor. 
157 
1) Plasminogen activator inhibitor (PAI) 
Voyager Spec #1=>AdvBC(1000,0.2,0.1>=>SM5=>MC[BP = 842.6, 10963] 
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3) Alpha-l-inhibitor III 
Voyager Spec #1=>AdvBC(1000,0.2,0.1)=>SM5=>MC[BP = 842.6, 11768] 
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4) Angiopoietin 2 (Ang-2) 
Voyager Spec #1=>AdvBC(1000,0.2,0.1)=>SM5=>MC[BP = 656.1, 1327] 
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5) Placental prolactin-like protein B (PLP-B) 
Voyager Spec #1=>AdvBC(1000,0.2,0.1)=>SM5=>MC[BP = 568.2. 3480] 
… 568.2238 
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6) Viperin 
Voyager Spec #1=>AdvBC(1000’0.2，0.1)=>SM5=>MC[BP = 515.4, 14454] 
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7) Contrapsin C-term 
Voyager Spec #1=>AdvBC(1000,0.2,0.1)=>SM5=>MC[BP = 842.6, 11508] 
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8) Trypsin-like protease p98 
Voyager Spec #1=>AdvBC<1000,0.2’0.1)=>SM5=>MC[BP = 656.1, 1557] 
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9) Protein FAM20B precursor 
V o y a g e r S p e c # 1=>Ad vBC ( 1 0 0 0 , 0 . 2 , 0 . 1 ) =>SM5=>MC [ BP = 656 . 1 . 9 63 ] 
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Representative two Dimensional Electrophoresis profiles of 72 h post coital uterine 
fluid flushings from SH, V P X and T X groups. The proteins are first separated on a 
13 cm immobiline drystrip, pi 3-10 and then by a 12 % homogenous SDS-PAGE. 
Finally the protein spots are visualized by silver staining. The spots on three gels are 
matched and analyzed by PDQuest software under predetermined matching criteria. 
Details are described in Materials and Methods. Data are summarized in Fig 3-9. 
Spots appear in all three gels are indicated by blue circles. Spots only found in SH 
and V P X gels or SH and T X are indicated by red and green circles respectively. 
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Venn diagram to show number of protein spots detect in uterine fluid flushings from 
the three experimental groups. This diagram shows data from 72 h post-coital 
sample which separated on pi 3-10 gel. The red, blue and yellow circles represent 
SH, V P X and T X groups respectively. The areas of overlap between the groups 
indicate the spots that are common to the groups. Protein profile for 72 h post-coital 
uterine fluid flushings on 2-DE gel are shown in the table. The 2-DE gels from V P X 
and T X groups were compared with SH group. The number of matched spots and 






Number of Protein Spots Detected in Uterine Fluid Flushings Collected from 
Females Mated With SH, VPX and TX Males at 72 h after Mating 
Number # of Spots # of Spots # of Spots 
pi range Groups of Spots matched ^—regulated down-regulated 
Detected with SH ^ - h e : 二 a r e 〜 卜 � ： : ^ 
SH 362 ~ ~ ~ 
3 to 10 VPX 268 184(69) 61 123 
TX 310 192 (62) 74 118 
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Fig. 3-10 
Representative two Dimensional Electrophoresis profiles of 72 h post coital uterine 
fluid flushings from SH, V P X and T X groups. The proteins are first separated on a 
13 cm immobiline drystrip, pi 4-7 and then by a 12 % homogenous SDS-PAGE. 
Finally the protein spots are visualized by silver staining. The spots on three gels are 
matched and analyzed by PDQuest software under predetermined matching criteria. 
Details are described in Materials and Methods. Data are summarized in Fig 3-11. 
Spots appear in all three gels are indicated by blue circles. Spots only found in SH 
and V P X gels or SH and T X are indicated by red and green circles respectively. 
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Fig. 3-11 
Venn diagram to show number of protein spots detect in uterine fluid flushings from 
the three groups. This diagram shows data from 72 h post-coital sample which 
separated on pi 4-7 gel. The red, blue and yellow circles represent SH, V P X and T X 
groups respectively. The areas of overlap between the groups indicate the spots that 
are common to the groups. Protein profile for 72 h post-coital uterine fluid flushings 
on 2-DE gel are shown in the table. The 2-DE gels from V P X and T X groups are 




織 ^ ^ ^ ^ ^ 
VPX ^ ^ ^ ^ ^ ~ TX 
326 538 
Number of Protein Spots Detected in Uterine Fluid Flushings Collected from 
Females Mated With SH, VPX and TX Males at 72 h after Mating 
T^T 1 n nc ^ # Of SOOtS # Of SpOtS Number # of Spots i … � i � T ^ ^ i i j up-regulated down-regulated pi range Groups or Spots matched i i 
Detected with SH (•/•) when 二 a r e when compare 
\ ， with SH with SH 
SH 592 - - --
4-7 VPX 326 284 (87) 68 216 











































































































































































































































































































































































































































































































































































































































72 h post-coital uterine fluid flushings from the three groups separated by 2-D 
electrophoresis as described in Materials and Methods. Nine spots that shows 
significant differential expression are highlighted. These spots are identified by 
MALDI-TOF analysis. The intensities of V P X spots are highest among the three 
groups for spots 1 and 2. The intensities of spots in the three groups are close for 
spots 3, 4 and 5. The intensities of T X spots 6, 7, 8 and 9 are the highest and 
follows by VPX. 
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72 h spot 3—Trypsin-like protease p98 
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72 h spot 6 —Beta actin (p-actin) 72 h spot 8—Osteoclast differentiation factor (ODF) 
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72 h spot 7 —Growth differentiation factor 8 72 h spot 9—Tumor necrosis factor alpha 
(GDF-8) induced protein 6 (TSG-6) 
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Fig. 3-13 
Representative spectra obtain from MALDI-TOF analysis. The protein spots are 
picked from 72 h post coital uterine fluid flushing 2-D gels. Each protein spot are 
digested by trypsin overnight, then mixed with matrix and placed on sample plate for 
analysis. Each peak on the spectrum represents a single digested peptide, and the 
mass of it are shown on the top. Nine identified proteins includes: 1) Prolactin-like 
protein F, 2) Alpha-2|Li globulin PGCL5, 3) Trypsin-like protease p98, 4) Interleukin 
12b p40 subunit, 5) Prolactin-like protein I, 6) Beta actin (P-actin), 7) Growth 
differentiation factor 8 (GDF-8), 8) Osteoclast differentiation factor (ODF), 9) 
Tumor necrosis factor alpha induced protein 6 (TSG-6). 
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1) Prolactin-like protein F 
Voyager Spec #1=>AdvBC<1000,0.2,0.1)=>SM5=>MC[BP = 656.5’ 9674] 
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499.0 1199.4 1899.8 2600.2 3300.6 4001.0 
Mass (m/z) 
2) Alpha-2p globulin PGCL5 
Voyager Spec #1=>AdvBC(1000,0.2,0.1)=>SM5=>MC[BP = 656.3，8231] 
側 656.2948 8231.5 
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3) Trypsin-like protease p98 
Voyager Spec #1=>AdvBC(1000，0.2’0."0=>SM5=:>MC[BP : 656.2, 6937] 








40 _ 842.6330 
1567.9225 
30- 147919659 
515.似 5 ^39.9)11 
20-
568.： 249 927.6307 1640.1006 2046.2484 
10- I 1345 8： 97 liifiniv;^ ooio-^ oftA 2808.5258 3339.8939 
I & 叠 ⑶ 。 ,,.於，•严，0 
299.0 11M.4 1B99.8 2600.2 3300.6 4001.0 
Mass (m/z) 
4) Interleukin 12b p40 subunit 
Voyager Spec #1=>AdvBC(1000,0.2,0. •0=>SM5=>MC[BP = 656.5，19303] 
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5) Prolactin-like protein I, 
Voyager Spec #1=>AdvBC(1000,0.2,0.1>=>SM5=>MC[BP = 1193.3, 13151] 
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6) Beta actin (P-actin), 
Voyager Spec #1=>AdvBC(1000,0.2,0.1)=>SM5=>MC[BP = 1516.8’ 5014] 
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7) Growth differentiation factor 8 (GDF-8), 
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8) Osteoclast differentiation factor (ODF) 
Voyager Spec #1=>AdvBC(1000,0.2,0.1)=>SM5=>MC[BP = 655.9, 5677] 
1 的 655.9353 5&76.S 
90 
80-






郷 丨 鄉 2808.7269 
20' 3339.0582 
10- 679 3915 1573.5321 llj 2663.84 JO . . . . ^^^ 3638.1265 
1；99.4 - • " " ^ . " - • ― 如 . 8 2600.2 3300.6 狐 0 
Mass (m/z) 
176 
9) Tumor necrosis factor alpha induced protein 6 (TSG-6) 
Voyager Spec #1=:>AdvBC(1000,0.2,0.1>=>SM5=>MC[BP = 656.1, 2065] 
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RT-PCR analysis of 72 h post coital uterus tissue taken from the three groups. RT-
PCR is conducted with specific primers for GDF-8. P-actin primers are co-run with 
the DGF-8 primers as an internal calibration. Lane 1 is the D N A ladder, two bands 
are obtained for three samples which are 1128 bp (p-actin) and 342 bp (GDF-8). All 
primers for this study are designed with Primer 3 online program, and synthesized by 
Invitrogen Life Technologies, Hong Kong. Primers used for RT-PCR are listed in 
the accompanying table. 
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72 h p.c. uterine tissue 
SH VPX TX 
1100 bp P-actin 
bp 
GDF-8 
bp B H S H j ^ H H H i i ^ H 
Primer information for GDF-8 and (3-actin 
Primer Name Sequence Product Size 
GDF-8 Forward GTGGATGGAAAACCCAAATG 
342 
GDF-8 Backward TGGTCCTGGGAAGGTTACAG 
P-actin Forward ATGGATGACGATATCGCTGCG 
P-actin Backward CTAGAAGCATTTGCGGTGGAC  
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Fig. 3-15 
The nucleotide sequence analysis of the PCR products. The sequencing result is 
submitted to "Nucleotide Nucleotide BLAST (blastn) sequence analysis services". 
The result shows that the 72h-spots 7 is Mus muscuius GDF-8 which is same as the 




Growth differentiation factor 8 (Gdf8), mRNA 
Length = 2676 
Score = 472 bits (238) 
Expect - e-130 
Identities = 283/298 (94%) 
Strand = Plus / Plus 
Hamster: 5 aaatccagtacaacaaagtagtgaaagcccagctgtggatccatctgagaccagtcaaga 64 
I I I I I I M I M I M I I I I I I I I I I I I I I I I I I I M 丨丨 I I I I m i l I M 丨 I M 
Mouse : 540 aaatacagtacaacaaagtagtaaaagcccaactgtggatatatctcagacccgtcaaga 599 
Hamster: 65 ctcccacaacagtgtttgtgcagattctgaggctcatcaaacccatgaaagacggtacaa 124 
I I I I I I I I I I I M I I I I I I I I I I I I I I I I I I M I I I I I I I I I I I I I I I I I I I I I I I 
Mouse : 600 ctcctacaacagtgtttgtgcaaatcctgagactcatcaaacccatgaaagacggtacaa 659 
Hamster: 125 ggtacactggaatccgatctctgaaactcgacatgagcccaggcactggcatttggcaga 184 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Mouse : 660 ggtatactggaatccgatctctgaaacttgacatgagcccaggcactggtatttggcaga 719 
Hamster: 185 gtattgatgtgaagacagtgttgcaaaattggctcaaacaacctgaatccaacttaggca 244 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Mouse : 720 gtattgatgtgaagacagtgttgcaaaattggctcaaacagcctgaatccaacttaggca 779 
Hamster: 245 ttgaaatcaaagctttggatgagaatggccatgatcttgctgtaaccttcccaggacc 302 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Mouse : 780 ttgaaatcaaagctttggatgagaatggccatgatcttgctgtaaccttcccaggacc 837 
181 
Fig. 3-16 
The length for GDF-8 PCR product is 302 bp. The sequence is matched with the 
human, mouse and rat sequence, and the result is shown. The hamster sequence 
share 94% homology with mouse and rat sequences. Also share 92% with human 
sequence. 
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tDFo 5 40 A AT &TT &CTT C TTT kk ATTT 590 
&DrO House 51? A AT&TT &CTTTTTT AA ATTT A&CTCT A一A|ACil&T AC A‘CAAA&T A—T A嗎a| 566 
tDFu Rat 410 A AT&TT &CTTTTTT AA ATTT A & C T C T A A C AaCAAAGT&&T AjJ^ I 460 
GBFO Hm.ian 591 |CCCi^剩AT|AT嘲画GS^C网C网ACTCC|T—AACA&T&TTT&T&Cl 641 
tDFC House 567 CCCl^伞T命GGATAT伞GACTCCTACAACACTCTTTCT&C 620 
OTFo Rat 464 IC C C flGCT &T&& AT AT AT c|qA& flGC C &T C M& ACT C C T AC hkC ACT GT TT &T & C 517 
tDFO Hmnajx AAACCpjAT&A&A&AC &&TAC AA&CT A^ f^c&AATC C| 101 
GDFO 621 h AAT|C C T & AC A CT C AT C A A AC CCAT&A hk&AC G&T AC A A&&T AI AC! & G/ikT C C 674 
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tDFo HUT., on T02 AT CT C T & A A A CT|rj&AC AT^ T (TgC & GA^ IATT & AT 4 755 
tDFC House 575 G AT CT C T Ghhh CT T &AC AT C C A& &C ACT &&T ATT T GCC A ATT & AT i IZ^  
tDFO r.it 572 GATCTCT&A&ACTI&ACiT&«&!cCCA&&CACT&&TATTT&GCAATT&AT3 625 
OTFO 140 AT CT C T&&&& Cljc^ AC AT CC&GGC &CT Gqcj&TT T GGC A ATT &AT j 190 
tDFo TS6 ^ G AA&A C ACT CTT &C AA A ATT G &CT C A AACg AlC CT & AAT C C A A CTT A& &C ATT 6�09 
GDrO House 729 T & A A& A C ACT &TT G-C A A A ATT & &CT C A A ACl & C CT G A AT C C A A CTT A& &C ATT f TOS 
tDFC Rit 6 26 t &AA&A C A&T &TT GC AA AATT & &CT C A AACa & C CT &AAT C C A A CTT A& &C ATT 6 £79 
OTFC HaTM5t4E 134 jc&&A&ACA&T&TT&CkhA&TT&&CTC&&AC||A|CCT&&ATCC&&CTTA&GC&TTd 247 
OTFo Hm,丨 an 010 \h AATIAJSi AACCT TTI A&AT G AC A AT^IC AT & AT CTT &C T CT i AC CTT C C C AC&A C| 060 
Qr-DTO House 70? ^ A AT C A A A&CT TT && AT & AC A AT &dc C AT & AT CTT &C T CT A AC CTT C C C A&G A C C06 
GOrG Rat 600 A AAT C A A A&CT TT G-&&T & A&A AT AT & AT CTT &C T CT AAC CTT C C C A&&A C TO? 
&DrO IlajMSttJ： 2 4u |&&&T|c|A&&&CTTT|&fiftT &&&&AT&G|c|c AT&&T CTT&CT&T&AC CTTCC CA&&AC| ?01 
G-DFG Hm..an C64 0 A&G A& A A&AT &&&CT & AAT C C &TTTT T At &T C A A& &T A AC A&AC A C AC C A A 917 
tDrO House 007 C A&&A& AA&&T &&&CT& AATCC CTTTTT A&AA&TC AA&&T&AC A&AC AC ACCC A 090 
OTFO P.it C A&&A& A At AT &&&CT & A AT C C CTTTT T A&A A &T C AAA &T A AC A&AC A C AC C C A 7G7 
&DrO HaiHStei: OOZ § 
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Fig. 3-17 
The 72 hp.c. uterine fluid flushing proteins are separated on a 13 cm immobiline dry 
strip, pi 3-10 and then by a 12 % homogenous SDS-PAGE. After 2-D 
electrophoresis, the gel is transblotted to nitrocellulose membrane. The membrane 
incubate with polyclonal mouse anti-goat growth differentiation factor-8 (GDF-8) 
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Chapter 4 General Conclusion 
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4.1. Conclusion 
The existence of a role of male accessory sex secretions on fertility has 
been demonstrated in several laboratory rodents. In vivo studies reveal that 
removal of some or all male accessory sex glands reduces fertility in the mouse 
(Pang et al., 1979; Peitz et al., 1986)，hamster (Chow et al., 1986) and rat (Queen 
et al, 1981; Carballada and Esponda 1992). 
The consequence of removal of the ventral prostate glands in reproduction 
w vivo has been studied in greater depth in the golden hamster. In this model, the 
A S G are surgically removed and different aspects of reproductive performance 
assessed. The rate of fertilization in vivo and in vitro are not affected (Chow et 
a/.’ 1986; Ying et al., 1999). Ying has reported that the treatment could delay 
oocyte activation with respect to Ca^^ oscillation, sperm nuclear decondensation, 
resumption of meiosis of the oocyte, pronuclear development and also D N A 
synthesis in the first cell cycle (Ying et al, 1998, 1999a and 1999b). Deletion of 
the ampullary glands and ventral prostates slow down cell division of embryos 
and a significant implantation loss is observed at 122 hp.c. (O et al., 1988). A 
significant number of embryos die at mid-gestation, even though the ones that 
survive have normal external features (Chow et al., 1989). Recent studies in 
hamster from Chan (2001) demonstrates developmental aberrations from the two-
cell to morula stages and a higher incidence of apoptosis at 70 h px.. 
Furthermore, implanted embryos have lower cell proliferation index, more 
necrotic cell death, display a range of gross structural abnormalities and have 
higher lethality rate (Jiang et al., 2001a). Termination of pregnancy appears to be 
initiated by failing embryos (Jiang et al., 2001b) 
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In this study, the fate of ventral prostate secretory proteins and effects of 
removal of male ventral prostate glands on protein compositions of uterine fluid 
flushing at the time of mating and periimplantation were investigated in the 
hamster. Proteomic techniques such as 2-D gel electrophoresis, MALDI-TOF 
were used to identify the proteins in this study. 
This study has demonstrated that the majority (72%) of VP secretory 
proteins are bound onto the sperm membrane. Several identified SBVPP 
components belongs to the kallikrein family such as kallikrein 3 (PSA), kallikrein 
4 and kallikrein 10. Besides kallikrein, PAP was also identified. All these 
proteins have proteolytic activity. W e suggest that this arrangement may help the 
sperm travel through the female reproductive tract by digesting uterine matrix 
proteins and reach the oocyte in the oviduct. About 16% of VP secretory proteins 
remain in the 1 hp.c. uterine fluid flushing. Besides ventral prostate, secretory 
proteins from other accessory sex glands are still found in 1 h p.c. uterine fluid 
flushing. It has been reported that phagocytes remove semen within the first 2 
hours after mating. However, our analysis shows that accessory sex gland 
secretory proteins which constitute seminal plasma, may not completely evacuated 
from the uterus p.c.. 
At 1 h p.c. and 4 h p.c., the protein concentration in VPX and TX are 
lower compared with SH. This may be due to the smaller volume of seminal 
plasma were introduced into the female. Degradation of sperm may raise the 
protein concentration inside the uterine lumen at 4 h p.c” therefore, the 
concentration in 4 h p.c. fluid are higher compared with 1 h p.c. uterine fluid 
flushings in the three groups. In 1 hp.c. uterine fluid flushing, the largest number 
of proteins is detected in VPX group. This result indicates that more kinds of 
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proteins were found in female uterus which had mated with V P X male. The 
numbers of spots common to V P X and T X are the least among the three groups in 
Ih and 4h p.c. sample. It reflects that omission of VP alone from the ejaculate 
induces a larger change in uterine fluid protein than the control. This probably 
due to the reduction of proteolysis in the absence of proteases from VP. 
Serum albumin is found in all of the 2-D gels in this study. It is also 
bound to sperm membrane. Serum albumin can induce acrosome reaction 
(Ellington et al, 1999). This may account for the fact the removal of even all 
A S G does not affect fertilization rate (Ying et aL, 1999a). 
A comparison of 2-D gel profiles of 60 and 72 hp.c. uterine fluid flushing 
shows that the presence of implanting embryo induces quantitative and qualitative 
changes in soluble proteins in the uterine lumen despite the fact that protein 
concentrations remain at about the same level. Ablation of the accessory sex 
glands does induce further changes of the uterine protein compositions. This can 
be attributed to long term systematic effect of A S G secretions on uterine fluid and 
the quality of the developing embryos. 
In this study, 18 protein spots are identified for 60 and 72 h p.c. uterine 
fluid flushing; and most of them are protease inhibitor and inflammatory proteins. 
Protein and m R N A expression of GDF-8 is demonstrated. Protein expression of 
GDF-8 remains the same for the three groups in 72 h post coital uterine fluid 
flushing. However, the m R N A expression in V P X group is much higher. m R N A 
expression of TSG-6 is demonstrated, the expression for the three groups remain 
the same. W e also found that TSG-6 appears in both post coital and 
periimplantation uterine fluid flushing. Three prolectin like proteins are found in 
periimplantation uterine fluid flushing. Since previously studies have been shown 
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that it is a pregnancy related protein, however prolactin like protein has never 
been found in this stages of pregnancy. 
4.2. Further Studies 
During to the limited time of this study, lot of further work need to be done 
in the future. A total of 43 protein spots are identified by MALDI-TOF in this 
study; however, only two of them are confirmed. In the future, the confirmation 
of these proteins can be done by PGR and western blotting, same as what we have 
done for TSG-6 and GDF-8. Furthermore, the functions of these proteins need to 
be explored as some of them have never been found in the uterus or uterine fluid 
before. Resources allowed, the scope of investigation can be extended to the 
hundreds of spots that appear on the 2-D gels. A full study of these will no doubt 
broaden and deepen our understanding of the uterine fluid in reproduction and 
male factor originated pregnancy failure. 
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General Solutions and Buffers 
1. Bromophenol blue (1%) 
O.lg bromophenol blue 
Add 10 ml distilled water 






1 tablet of protease cocktail inhibitor (Roche, Germany) 
Add Milli Q water to 7 ml 
3. Paraformaldehyde (PFA, 4%) Solution 
4g paraformaldehyde 
Heat 50 ml 0.2 M phosphate buffer to around 90。C, then add PFA and 
adjust the volume to 100 ml by adding distilled water 
4. Phosphate Buffer (0.2 M) 
II.39g NaH2P04 
57.49g di-sodium hydrogen phosphate 
Add 2L distilled water then adjust to pH 7.4 and bring to 2.5 L 
5. Phosphate Buffered Saline (PBS) (0.1 M, pH 7.4) 
Stock solution: 14g di-sodium hydrogen phosphate 
80g sodium chloride 
2g potassium chloride 
2.4g potassium dihydrogen orthophosphate 
Add 80 ml distilled water then adjust pH to 7.4 and 
bring to 100 ml 
Working solution: 100 ml stock solution 
Add 900 ml distilled water 
6. PBSAT Buffer 
O.lg bovine serum albumin (BSA) 
50|il Triton X-100 
Add to 100 ml IX PBS 
7. PBST Buffer (0.05% Tween 20 /PBS) 
100m" OX PBS 
500|li1 Tween-20 
Add distilled water to IL 
8. Suspension Buffer (pH 7.4) 
in 2 ml of 0.5% NP-40 made up in 5 m M HEPES/0.264mM sucrose 
buffer, containing 2 m M phenylmethylsulfonyl fluoride (PMSF), 10 
m M iodoacetamide 
9. Saline (0.85%) 
212 
8.5g sodium chloride 
Add distilled water to IL 
10. SDS (10%) 
lOg SDS dissolved in 100ml distilled water 
11. Sodium Thiosulplate Solution 
5g sodium thiosulplate dissolved in 100 ml 
12. Tris Buffered Saline (TBS) 
12.12g Tris 
Add 1.8 L distilled water then adjust pH to 7.6 and bring to 2 L 
13. Tris-HCl (0.5M) 




Buffers and Solutions for Electrophoresis 
1. Acrylamide stock (49.5% T, 3% C, keep in a foil wrapped bottle) 
240g acrylamide monomer 
7.5g bis-acrylamide 
Add Milli Q water to 500 ml 
2. Agrose (1%) 
Ig agrose 
dissolved in 100ml upper buffer working solution 
3. Ammonium persulfate (10%) 
Ig Ammonium persulfate dissolved in 10ml distilled water 
4. Anode (lower) Buffer (pH 8.9) 
Stock solution: 242.2g Tris 
Add 600 ml Milli Q water then adjust pH to 8.9 with 
H C L and bring to 1 L 
Working solution: 100 ml stock solution 
Add 900 ml Milli Q water 
5. Cathode (upper) Buffer 
Stock solution: 60.6g Tris 
89.6g tricine 
5g SDS 
Add Milli Q water to 500 ml 
Working solution: 100 ml stock solution 
Add 900 ml Milli Q water 
6. Developing Solution 
500)^ 1 formaldehyde 
15g sodium carbonate 
20jil 50mg/ml sodium thiosulplate 
Add Milli Q water to 500 ml 
7. Equilibration Buffer 
180g urea 
lOg SDS 
166 ml 100% glycerol 
16.75 ml 1.5M Tris (pH8.8) 
Add Milli Q water to 500 ml 
8. Fixation Solution 1 
250 ml methanol 
60 ml acetic acid 
0.5 ml 37% formaldehyde 
Add Milli Q water to 500 ml 
9. Fixation Solution 2 
2 ml sodium thiosulplate solution in 500ml Milli Q water 
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10. Gel Buffer (pH 8.45) 
181.7g Tris 
1.5g SDS 
Add 500 ml Milli Q water, adjust pH to 8.45 with HCl before adding 
SDS 
11. Glycerol (50%) 
250ml Glycerol mixed with 250ml Milli Q water 
12. Rehydration Buffer 
0.75g urea 
0.0317g CHAPS 
0.0 Ig D T T 
Add Milli Q water to 1.5 ml 
Add 10|Li IPG buffer into 1 ml of the above solution 
13. Silver Solution 
0.75 g silver nitrate 
375jLi l formaldehyde 
Add Milli Q water to 500 ml 
14. Stop Buffer 
50g Tris 
20ml acetic acid 
Dissolved in 980ml Milli Q water and then add acetic acid 
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Appendix C 
Solutions and Buffers for Immunoblotting 
1. Blocking Solution (5% milk/PBST) 
5g blocking grade non-fat dry milk dissolved in 100ml PBST 
2. Citrate Stock A (O.IM) 
29.4g Tri-sodium citrate 
Add 800 ml distilled water then adjust pH to 6 and bring to IL 
3. Citrate Stock B (O.IM) 
10.5g Citrate acid 
Dissolved in 500 ml distilled water 
4. Citrate Buffer (0.05M, pH 6.0) 
410 ml O.IM Citrate Stock A 
Add O.IM Citrate Stock B to adjust pH to 6, then add distilled water to 
1 L 
5. Running Buffer (0.025M Tris, pH8.3) 
Stock solution: 60.6g Tris 
285.3g Glycine 
lOg SDS 
Add HCl to adjust pH to 8.3, then add distilled water to 
2L 
Working solution: 100 ml stock solution 
900 ml distilled water 
6. Transfer Buffer 
Stock solution: 60.5g Tris 
288g Glycine 
Add distilled water to 2L 
Working solution: 100ml lOX transfer buffer 
100ml methanol 
Add 800ml distilled water 
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Appendix D 
Solutions for MALDI-TOF 
1. 50% Acetonitrile/25mM Ammonium bicarbonate solution 
50ml A C N mix with 50 ml 5 0 m M Ammonium bicarbonate 
2. 50% Acetonitrile/5% Trifluoroacetic acid solution 
50ml A C N mix with 5ml TFA, then bring to 100ml with Milli Q water 
3. 50% Acetonitrile/0.3% Trifluoroacetic acid solution 
50ml A C N mix with 300^1 TFA, then bring to 100ml with Milli Q 
water 
4. 50% Acetonitrile/0.1% Trifluoroacetic acid solution 
50ml A C N mix with 100|ul TFA, then bring to 100ml with Milli Q 
water 
5. 25mM Ammonium Bicarbonate solution 
0.197g Ammonium Bicarbonate 
Dissolved in 80ml Milli Q water, adjust pH to 8 then bring to 100ml 
6. 50mM Ammonium Bicarbonate solution 
0.395g Ammonium bicarbonate 
Dissolved in 80ml Milli Q water, adjust pH to 8 then bring to 100ml 
7. Matrix solution (CHCA) 
0.5g purified C H C A dissolved in 2 ml 2 5 m M Ammonium Bicarbonate 
8. 30mM Potassium Ferricyanide solution 
0.99g Potassium ferricyanide 
Dissolved in 100ml Milli Q water 
9. Purified a-cyano-4-hydroxy-cinnamic acid (CHCA) 
5 g C H C A dissolved in 5 ml warm methanol, filter with Whatman 
No. 1 filter paper. Elute was cooled down and poured on filter paper 
until dried 
10. lOOmM Sodium Thiosulfate solution 
1.58g Sodium thiosulfate 
Dissolved in 100ml Milli Q water 
11. Trypsin solution 
20|Lig sequencing grade modified trypsin dissolved in 2 ml 50% 
Acetonitrile/5% Trifluoroacetic acid solution 
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Appendix E 
Solutions for Polymerase Chain Reaction 
1. 2% Agrose 
1 g agrose 
Dissolved in 50ml 0.5X TBE buffer 
2. DNase Incubation Mix 
40 |Lil yellow care buffer 
5 |Lil 0.09M M n C b 
5 jLil DNase I enzyme 
3. 0.1% Ethidium Bromide staining buffer 
500 ethidium bromide 
500 ml 0.5X TBE buffer 
4. Reverse Transcription Mix 
5 111 lOX PGR buffer 
5 j^l lOmM dNTP 
5 |Lil 5 0 m M MgCl2 
10 jLil O.IMDTT 
15 jul DEPC water 
5. Tris-boric Acid-EDTA (TBE) 
Stock solution: 108g Tris base 
55g Boric acid 
7.44g E D T A 
Add 800 ml distilled water then adjust pH to 8.3 and 
bring to 1 L 
Working solution: 100 ml stock solution 
Add 900 ml distilled water 
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Appendix F 
Standard & Marker Lists 
1. ID Molecular Weight Marker (Fermentas Life Sciences, Lithuania) 
Protein Source Molecular weight 
(kPa)  
P-galactosidase E.coil 116.0 
Bovine serum albumin Bovine plasma ~662 一 
Ovalbumin Chicken egg white ~45.Q “ 
Lactate dehydrogenase Porcine muscle ~35.0 — 
Restriction endonuclease Bsp 981 E.coil 25.0 
P-lactoglobulin Bovine milk 18.4 
Lysozyme Chicken egg white 14.4 
2. ID Prestained SDS-PAGE Standards, Broad Range (Bio-Rad, Hercules, 
CA) 
Protein Source Molecular weight 
(kPa)  
Myosin Rabbit skeletal muscle 209.0 
p-galactosidase E. coil 124.0 
Bovine serum albumin Bovine plasma 80.0 
Ovalbumin Chicken egg white  
Carbonic anhydrase Bovine erythrocytes 34.8 
Soybean trypsin inhibitor Soybean 28.9 
Lysozyme Chicken egg white 20.6 
Aprotinin Bovine pancreas 7_A  
3. 2D Molecular Weight Marker (Bio-Rad, Hercules, CA) 
Protein Molecular weight pi 
(kPa)  
Hen egg white conalbumin type I 76 6.0, 6.3, 6.6 
Bovine serum albumin (BSA) 66.2 5.4, 5.6 
Bovine muscle actin ^ 5.0, 5.1 
Rabbit muscle glyceraldehyde 3- 36 8.3-8.5 
phosphate dehydrogenase  
Bovine carbonic anhydrase ^ 5.9,6.0 
Soybean trypsin inhibitor  
Equine myoglobin 17.5 7.0 
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4. 100 bp DNA Ladder (Invitrogen, Carlsbad, CA) 
Consists of 15 blunt-ended fragments between 100 and 1500 bp in multiples of 
100 bp and an additional fragment at 2072 bp. The 600 bp band is 
approximately 2 to 3 times brighter than the other ladder bands to provide 
internal orientation. 
5. SequazymeTM Peptide Mass Standard Kit (Applied Biosystems, Foster 
City, CA) 
Standard Component (M+nH)ii+ (M+nH)n+ 
Average monoisotopic 
Calibration Mixture 1 Des-Arg-Bradykinin 905.05 904.4681 
Angiotensin I 1297.51 1296.6853 
Glu-Fibrinopeptide B 1571.61 1570.6774 
Neurotensin 1673.96 1672.9175 
6. Complete, Mini, EDTA Free Protease Inhibitor Cocktail Tablets (Roche, 
Germany) 
Protease Enzyme concentration (mg/ml) 
Pancreas extract 0.02 
Chymotrypsin 0.002 “ 







Concentration [" ‘ “ 
(mg/ml) 1.6000 3.2000 6.4000 9.6000 
0-3560 0.5820 1.0000 1.4090 
0-3635 0.5838 1.0220 1.4320 
0-3689 0.5765 1.0225 1.4220 
^ ^ +⑶； Q-3625 0.5825 1.0125 1.4362 
OD at 595   
0-3710 0.5768 1.0236 1.4360 
0-3605 0.5821 1.0196 1.4320 
0.3611 0.5749 1.0258 1.4390 
0-3558 0.5819 1.0269 1.4286 
Average OD 0.3624 0.5801 1.0191 1.4294 
Protein Assay 
1 2 . 0 0 0 0 � 
—、 S 10.0000 -
WD ^ ^ 
^ 8.0000 -
6.0000 - Z 
2 Z 
g 4.0000 - ^ ^ y = 7.4793x- 1.1404 
fi R2 = 0.9997 
o 2.0000 - Z 
0.0000 J , , , , 
0.0000 0.5000 1.0000 1.5000 2.0000 




1. SDS PAGE Preparation 
2-DE separating and stacking gels were prepared as detailed in the following 
tables. All reagents were kept for a maximum of three months. For gels 
prepared for 1-DE, 1/10 of the volume listed below was used. 
12% Separating Gel  
16ml Glycerol  
37ml — 49.5% Acrylamide 
48ml ~~ Gel Buffer — 
43ml _ Milli Q Water 
720jLil “ 10% AP — 
72)LI1 T E M P D 
4% Stacking Gel  
I.2ml 49.5% Acrylamide 
3.7ml — G e l Buffer 一 
II.1ml 一 Milli Q Water 
140|li1 — 10% AP 
14^1 T E M P D 
2. lEF Program 





2000V — IQOQQVhr 
5000V — 25000Vhr 
Total Vhr 50000Vhr 
3. MALDI-TOF Database Search Criteria 
During peptide-mass fingerprinting search, the following criteria were applied. 
I. Protein Prospector Tools: M S Fit 
II. Database: NCBlnr. 10.21.2003 
III. Species: Rodent 
IV. Digest: Trypsin 
V. Max. # of missed cleavages: 2 
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VL Instrument: MALDI-TOF 
VII. Peptide masses are: monoisotopic 




A total R N A isolation kit was purchased from Promega Corporation, WI, U.S.A.. 
The tissue was ground with liquid nitrogen, and then transferred into a 2ml centrifuge 
tube. Within the same tube, 175 jul chilled R N A lysis buffer was added. Then 350^1 
R N A dilution buffer was added to the lysate and mix by inverting the tube end-to-end 
four times. The sample was placed on heat block at 7(fC for 3 min. After that, the 
sample was centrifuged at 13000g for 10 min. The clear supernatant was pipetted into 
a fresh 2 ml centrifuge tube, and 2 0 0 j L i l 95% ethanol was added. The content was 
mixed by pipetting up and down four times. Meanwhile the spin column and 
collection tube were assembled, and the mixture was transferred into the spin column 
and centrifuged at 13000g for 1 min. The collection tube was emptied and SOjul 
DNase incubation mix was added on the membrane inside the spin column and 
incubated for 15 min at room temperature. After incubation, 200JLI1 SV DNase stop 
solution was added to the spin column and centrifuged at 13000g for 1 min. The 
collection tube was emptied again, and 600jul DNase wash solution was added into 
the spin column and centrifuged at 13000g for 2 min. Finally, the spin column was 
coupled to the elution tube and the sample was eluted by adding 50jul Nuclease-free 
water onto the membrane and centrifuged at 13000g for 1 min. The eluted sample is 
ready for reverse transcription. 
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Appendix J 
Western Blot Analysis 
The western blotting was carried out on (BioRad, Hercules, CA). Once the 
electrophoresis was finished, the gel was removed from the cassette and transferred to 
the working transfer buffer. The gel was pre-incubated for 30 min with 2 changes of 
fresh working transfer buffer to stabilize the proteins in the gel and prevent shrinkage. 
Nitrocellulose membrane purchased from Bio-Rad (Hercules, CA) was equilibrated 
for 30min with 2 changes of Milli Q water followed by soaking in the transfer buffer 
for another 15 minutes on a shaker. At the same time, a 3 m m thick filter paper (Bio-
Rad, Hercules, CA) was also soaked in the working transfer buffer. The filter paper, 
gel, and membrane were assembled together, was taken to ensure that no bubbles 
were trapped between the gel and the membrane and that the orientation and order of 
the components were correctly positioned inside the cassette. Finally, the cassette 
was immersed buffer inside the transfer tank. Electroblotting was run at constant 
100mA and 4°C overnight. 
After the electroblotting, the membrane was removed and washed first with 
Milli Q water for 1 min and then PBST for 3 min. Non-specific binding was blocked 
by incubation in blocking solution for 1 hour on the shaker. After blocking, the 
membrane was incubated in the primary antibody of interest at 4°C overnight. On 
following day, the membrane was washed with 4 changes of PBST for 40 min. For 
secondary antibody incubation, the membrane was incubated in correspond IgG-HRP 
antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) diluted 1:2000 with PBS 
for Ih. Finally, immunoreactivity was by a D A B kit (ZYMED, CA. U.S.A) according 
to protocol provided by manufacturer (Appendix D). 
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Appendix K 
Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
Total R N A was extracted by R N A isolation kit (Promega, Madison, WI). The detail 
procedure was described on appendix 1. For RT-PCR, 40 R N A extract, 5^1 lOx 
PCR buffer and 5 |il oligo dT were added into a 0.5 jul microcentifuge tube. The 
mixture was incubated for 10 min on a 70^C heatblock. After incubation, 40 RT 
mix was added and incubated for another 5 min at 42 To start the reverse 
transcription, 10 |il reverse transcriptase (lOOU / 20 jul) was added and incubated for 1 
hour at 42。C. Finally, the reaction was stopped by placing the mixture on heat block 
at 70 oc for 15 min. The cDNA was stored at -20°C until used. 
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Appendix L 
Polymerase Chain Reaction (PCR) 
PCR reaction was performed in a Micro Amp® reaction tubes with cup (Applied 
Biosystems, Foster City, CA). The total volume of the mix was 25 |LI1 and contained 
0.7 ^il cDNA, 2.5 |li1 lOX PCR reaction buffer, 0.75 ^ il 5 0 m M MgCl�，0.5 jid lOmM 
dNTPs, 1.25U Taq-DNA polymerase (Amersham Bioscience, Sweden), 0.25 jiM 
sense, and 0.25 |liM antisense using a PTC-100™ Programmable thermal controller 
(MJ Research Inc., Watertown, MA). Amplification was performed as follows: 
Time Temperature Cycle 
4 min 9 4 ^ 
40 sec 25 
1 min 
10 min T ^ 1 
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Appendix M 
Protocol for Haematoxylin and Eosin Staining for Paraffin Section 
1. Dewax sections in xylene, and hydrate through graded alcohols to water 
2. Stain in an alum haematoxylin of choice for a suitable time 
3. Wash well in running tap water until sections blue (about 5 min) 
4. Differentiate in 1% acid alcohol (1% HCl in 70% alcohol) for 10 sec 
5. Stain in 1% eosin for 5 min 
6. Wash in running tap water for 5 min 
7. Dehyrate through alcohols 
8. Keep in xylene and mount in histological mounting medium (Permount ⑧， 
Fisher Scientific, NJ) 
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